id	sid	tid	token	lemma	pos
work_5r5e7ca2zncbpm64fpccqjkzhi	1	1	ONCOLOGY	ONCOLOGY	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	1	2	LETTERS	letter	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	1	3	1	1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	1	4	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	1	5	855	855	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	1	6	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	1	7	859	859	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	1	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	1	9	2010	2010	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	1	10	Abstract	Abstract	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	1	11	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	2	1	To	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	2	2	assess	assess	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	2	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	2	4	efficacy	efficacy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	5	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	6	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	2	7	additional	additional	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	2	8	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	9	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	10	transcatheter	transcatheter	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	2	11	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	2	12	chemoembolization	chemoembolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	13	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	2	14	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	2	15	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	2	16	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	17	percu-	percu-	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	2	18	taneous	taneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	2	19	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	20	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	21	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	2	22	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	2	23	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	2	24	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	25	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	26	relatively	relatively	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	2	27	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	2	28	hepatocellular	hepatocellular	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	29	carcinomas	carcinoma	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	2	30	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	2	31	HCCs	HCCs	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	2	32	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	2	33	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	2	34	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	2	35	multicenter	multicenter	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	2	36	randomized	randomized	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	2	37	control	control	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	38	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	39	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	2	40	RCT	RCT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	2	41	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	2	42	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	2	43	performed	perform	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	2	44	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	3	1	We	-PRON-	PRP
work_5r5e7ca2zncbpm64fpccqjkzhi	3	2	conducted	conduct	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	3	3	an	an	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	3	4	RCT	rct	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	3	5	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	3	6	follow	follow	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	3	7	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	3	8	up	up	RP
work_5r5e7ca2zncbpm64fpccqjkzhi	3	9	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	3	10	during	during	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	3	11	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	3	12	enrollment	enrollment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	3	13	period	period	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	3	14	from	from	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	3	15	1997	1997	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	3	16	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	3	17	1999	1999	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	3	18	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	4	1	Newly	newly	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	4	2	diagnosed	diagnosed	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	4	3	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	4	4	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	4	5	one	one	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	4	6	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	4	7	three	three	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	4	8	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	4	9	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	4	10	measuring	measure	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	4	11	from	from	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	4	12	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	4	13	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	4	14	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	4	15	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	4	16	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	4	17	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	4	18	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	4	19	maximum	maximum	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	4	20	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	4	21	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	4	22	diameter	diameter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	4	23	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	4	24	enrolled	enrol	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	4	25	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	5	1	A	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	5	2	total	total	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	5	3	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	5	4	30	30	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	5	5	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	5	6	initially	initially	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	5	7	underwent	undergo	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	5	8	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	5	9	combi-	combi-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	5	10	nation	nation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	5	11	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	5	12	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	5	13	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	5	14	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	5	15	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	5	16	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	5	17	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	5	18	therapies	therapy	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	5	19	at	at	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	5	20	eight	eight	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	5	21	randomly	randomly	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	5	22	assigned	assign	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	5	23	Japanese	japanese	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	5	24	hospitals	hospital	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	5	25	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	6	1	However	however	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	6	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	6	3	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	6	4	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	6	5	withdrew	withdraw	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	6	6	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	7	1	Of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	7	2	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	7	3	27	27	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	7	4	remaining	remain	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	7	5	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	7	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	7	7	13	13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	7	8	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	7	9	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	7	10	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	7	11	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	7	12	combina-	combina-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	7	13	tion	tion	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	7	14	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	7	15	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	7	16	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	7	17	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	7	18	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	7	19	14	14	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	7	20	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	7	21	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	7	22	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	7	23	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	7	24	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	8	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	8	2	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	8	3	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	8	4	observed	observe	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	8	5	over	over	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	8	6	several	several	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	8	7	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	8	8	[	[	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	8	9	median	median	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	8	10	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	8	11	inter-	inter-	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	8	12	quartile	quartile	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	8	13	range	range	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	8	14	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	8	15	33.2	33.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	8	16	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	8	17	24.6	24.6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	8	18	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	8	19	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	8	20	]	]	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	8	21	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	9	1	There	there	EX
work_5r5e7ca2zncbpm64fpccqjkzhi	9	2	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	9	3	no	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	9	4	significant	significant	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	9	5	differences	difference	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	9	6	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	9	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	9	8	background	background	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	9	9	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	9	10	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	9	11	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	9	12	between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	9	13	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	9	14	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	9	15	groups	group	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	9	16	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	10	1	Among	among	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	2	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	10	3	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	10	4	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	5	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	6	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	10	7	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	10	8	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	10	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	10	10	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	10	11	devel-	devel-	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	10	12	opment	opment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	13	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	14	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	10	15	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	10	16	residual	residual	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	10	17	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	18	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	10	19	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	20	significantly	significantly	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	10	21	lower	low	JJR
work_5r5e7ca2zncbpm64fpccqjkzhi	10	22	occurence	occurence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	23	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	10	24	compared	compare	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	25	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	26	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	10	27	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	28	receiving	receive	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	10	29	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	10	30	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	10	31	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	10	32	7.6	7.6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	10	33	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	10	34	42.9	42.9	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	10	35	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	36	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	10	37	respectively	respectively	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	10	38	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	10	39	P=0.024	p=0.024	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	10	40	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	10	41	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	11	1	However	however	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	11	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	11	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	11	4	mean	mean	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	11	5	cancer	cancer	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	6	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	11	7	free	free	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	11	8	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	9	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	10	absence	absence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	11	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	12	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	11	13	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	11	14	multiple	multiple	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	11	15	nodule	nodule	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	11	16	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	17	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	18	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	11	19	patient	patient	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	11	20	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	21	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	22	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	23	not	not	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	11	24	significantly	significantly	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	11	25	different	different	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	11	26	between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	27	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	11	28	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	29	groups	group	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	11	30	[	[	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	31	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	11	32	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	11	33	vs.	vs.	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	34	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	11	35	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	11	36	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	11	37	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	11	38	cancer	cancer	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	39	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	11	40	free	free	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	11	41	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	42	16.7	16.7	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	43	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	44	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	45	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	46	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	11	47	7.3	7.3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	48	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	11	49	26.0	26.0	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	50	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	51	vs.	vs.	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	11	52	22.9	22.9	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	53	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	11	54	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	55	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	56	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	57	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	11	58	12.4	12.4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	59	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	11	60	33.4	33.4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	61	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	62	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	11	63	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	64	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	65	57.2	57.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	66	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	67	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	68	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	69	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	11	70	37.2	37.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	71	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	11	72	77.2	77.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	73	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	74	vs.	vs.	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	11	75	42.4	42.4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	76	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	11	77	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	78	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	79	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	11	80	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	11	81	29.2	29.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	82	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	11	83	55.6	55.6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	11	84	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	85	]	]	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	11	86	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	12	1	Although	although	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	2	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	12	3	combination	combination	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	4	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	5	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	12	6	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	12	7	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	12	8	had	have	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	12	9	significant	significant	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	12	10	effects	effect	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	12	11	on	on	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	12	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	12	13	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	12	14	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	15	control	control	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	16	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	12	17	no	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	12	18	efficacy	efficacy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	19	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	20	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	12	21	addition	addition	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	22	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	23	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	12	24	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	25	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	12	26	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	12	27	noted	note	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	28	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	29	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	12	30	prognosis	prognosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	31	among	among	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	32	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	12	33	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	12	34	relatively	relatively	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	12	35	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	12	36	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	12	37	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	12	38	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	13	1	Introduction	introduction	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	2	In	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	3	Japan	Japan	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	13	4	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	13	5	hepatocellular	hepatocellular	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	6	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	7	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	13	8	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	13	9	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	13	10	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	13	11	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	13	12	major	major	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	13	13	health	health	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	14	concern	concern	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	15	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	16	an	an	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	13	17	incidence	incidence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	18	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	19	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	13	20	million	million	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	13	21	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	13	22	infected	infect	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	23	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	24	hepatitis	hepatitis	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	13	25	C	C	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	13	26	virus	virus	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	27	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	13	28	HCV	HCV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	13	29	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	13	30	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	13	31	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	32	7	7	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	13	33	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	13	34	8	8	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	13	35	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	36	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	37	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	13	38	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	39	liver	liver	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	40	cirrhosis	cirrhosis	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	13	41	developing	develop	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	13	42	de	de	FW
work_5r5e7ca2zncbpm64fpccqjkzhi	13	43	novo	novo	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	13	44	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	13	45	every	every	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	13	46	year	year	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	13	47	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	14	1	Moreover	moreover	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	14	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	14	3	approximately	approximately	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	14	4	35,000	35,000	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	14	5	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	14	6	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	14	7	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	14	8	succumbed	succumb	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	14	9	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	14	10	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	14	11	disease	disease	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	14	12	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	14	13	2009	2009	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	14	14	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	15	1	A	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	15	2	total	total	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	15	3	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	15	4	70	70	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	15	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	15	6	80	80	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	15	7	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	15	8	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	15	9	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	15	10	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	15	11	are	be	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	15	12	infected	infect	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	15	13	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	15	14	HCV	HCV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	15	15	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	15	16	approximately	approximately	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	15	17	20	20	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	15	18	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	15	19	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	15	20	hepatitis	hepatitis	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	15	21	B	B	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	15	22	virus	virus	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	15	23	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	15	24	HBV	HBV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	15	25	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	15	26	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	15	27	1	1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	15	28	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	15	29	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	16	1	It	-PRON-	PRP
work_5r5e7ca2zncbpm64fpccqjkzhi	16	2	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	16	3	estimated	estimate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	16	4	that	that	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	16	5	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	16	6	number	number	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	16	7	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	16	8	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	16	9	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	16	10	may	may	MD
work_5r5e7ca2zncbpm64fpccqjkzhi	16	11	increase	increase	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	16	12	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	16	13	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	16	14	next	next	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	16	15	10	10	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	16	16	years	year	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	16	17	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	17	1	Therefore	therefore	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	17	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	17	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	17	4	establishment	establishment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	17	5	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	17	6	effective	effective	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	17	7	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	17	8	modalities	modality	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	17	9	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	17	10	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	17	11	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	17	12	imperative	imperative	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	17	13	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	18	1	Percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	18	2	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	18	3	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	18	4	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	18	5	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	18	6	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	18	7	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	18	8	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	18	9	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	18	10	useful	useful	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	18	11	type	type	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	18	12	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	18	13	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	18	14	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	18	15	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	18	16	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	18	17	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	18	18	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	18	19	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	18	20	particularly	particularly	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	18	21	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	18	22	those	those	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	18	23	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	18	24	poor	poor	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	18	25	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	18	26	functional	functional	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	18	27	reserve	reserve	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	18	28	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	18	29	2,3	2,3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	18	30	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	18	31	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	19	1	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	19	2	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	3	involves	involve	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	19	4	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	19	5	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	6	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	7	absolute	absolute	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	19	8	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	9	into	into	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	10	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	19	11	using	use	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	19	12	ultrasound	ultrasound	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	19	13	guidance	guidance	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	14	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	19	15	resulting	result	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	19	16	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	17	cellular	cellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	19	18	dehydration	dehydration	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	19	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	19	20	coagulation	coagulation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	21	necrosis	necrosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	22	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	19	23	vascular	vascular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	19	24	thrombosis	thrombosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	25	within	within	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	26	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	19	27	treated	treated	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	19	28	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	19	29	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	19	30	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	19	31	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	19	32	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	20	1	Patient	patient	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	20	2	outcome	outcome	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	20	3	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	20	4	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	20	5	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	20	6	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	20	7	comparable	comparable	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	20	8	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	20	9	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	20	10	outcome	outcome	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	20	11	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	20	12	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	20	13	who	who	WP
work_5r5e7ca2zncbpm64fpccqjkzhi	20	14	undergo	undergo	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	20	15	surgical	surgical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	20	16	resection	resection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	20	17	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	20	18	5,6	5,6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	20	19	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	20	20	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	21	1	However	however	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	21	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	21	4	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	5	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	6	primary	primary	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	7	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	21	8	after	after	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	9	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	10	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	11	common	common	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	12	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	13	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	21	14	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	21	15	rate	rate	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	16	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	17	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	18	residual	residual	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	19	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	20	after	after	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	21	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	22	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	23	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	24	reported	report	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	25	Addition	addition	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	26	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	27	transcatheter	transcatheter	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	28	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	29	chemoembolization	chemoembolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	30	decreased	decrease	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	31	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	32	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	33	but	but	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	21	34	had	have	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	35	no	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	21	36	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	37	benefit	benefit	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	38	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	39	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	40	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	41	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	42	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	43	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	44	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	21	45	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	46	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	47	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	48	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	49	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	50	A	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	21	51	multicenter	multicenter	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	52	randomized	randomized	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	53	control	control	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	54	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	55	AkIRA	AkIRA	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	56	MIzukI1	MIzukI1	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	57	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	58	MAsAyukI	masayuki	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	59	TATEMICHI1,2	tatemichi1,2	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	60	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	61	NOBuHIRO	nobuhiro	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	62	TsukAdA1	TsukAdA1	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	63	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	64	RyOusukE	RyOusukE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	65	NAgAMATsu4	NAgAMATsu4	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	66	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	67	MITsuHIkO	MITsuHIkO	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	68	kAWAguCHI5	kAWAguCHI5	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	69	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	70	TATsuyA	TATsuyA	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	71	ITOsHIMA5	ITOsHIMA5	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	72	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	73	sHIgEkI	sHIgEkI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	74	MARuyAMA6	MARuyAMA6	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	75	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	76	ATsuHIkO	atsuhiko	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	77	sATOu7	sATOu7	''
work_5r5e7ca2zncbpm64fpccqjkzhi	21	78	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	79	yAsuHIsA	yasuhisa	ADD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	80	IMARI8	IMARI8	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	81	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	82	TOsHIHARu	toshiharu	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	83	kAWATOkO9	kawatoko9	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	84	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	85	JuNyA	JuNyA	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	86	sHIMONO9	sHIMONO9	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	87	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	21	88	HIROsHI	HIROsHI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	89	NAgATA3	NAgATA3	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	90	sAIsEIkAI	sAIsEIkAI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	91	AssOCIATION	AssOCIATION	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	92	fOR	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	93	THE	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	21	94	sTudy	sTudy	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	95	Of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	96	LIVER	LIVER	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	97	dIsEAsEs	dIsEAsEs	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	98	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	21	99	sAsLd	sAsLd	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	100	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	21	101	1department	1department	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	102	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	103	Internal	Internal	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	104	Medicine	Medicine	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	105	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	106	saiseikai	saiseikai	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	107	Central	Central	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	108	Hospital	Hospital	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	109	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	110	2department	2department	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	111	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	112	Hygiene	Hygiene	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	113	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	21	114	Preventive	Preventive	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	115	Medicine	Medicine	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	116	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	117	school	school	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	118	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	119	Medicine	Medicine	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	120	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	121	showa	showa	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	122	university	university	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	123	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	124	3department	3department	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	125	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	126	Internal	Internal	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	127	Medicine	Medicine	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	128	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	129	school	school	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	130	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	131	Medicine	Medicine	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	132	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	133	keio	keio	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	134	university	university	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	135	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	136	Tokyo	Tokyo	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	137	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	138	4department	4department	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	139	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	140	Internal	Internal	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	141	Medicine	Medicine	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	142	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	143	Nakatsu	Nakatsu	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	144	saiseikai	saiseikai	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	145	Hospital	Hospital	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	146	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	147	Osaka	Osaka	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	148	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	149	5department	5department	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	150	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	151	Internal	Internal	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	152	Medicine	Medicine	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	153	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	154	Okayama	Okayama	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	155	saiseikai	saiseikai	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	156	Hospital	Hospital	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	157	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	158	Okayama	Okayama	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	159	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	160	6department	6department	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	161	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	162	gastroenterology	gastroenterology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	163	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	164	gotsu	gotsu	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	165	general	general	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	166	Hospital	Hospital	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	167	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	168	shimane	shimane	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	169	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	170	7department	7department	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	171	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	172	Internal	Internal	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	173	Medicine	Medicine	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	174	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	175	kagawa	kagawa	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	176	saiseikai	saiseikai	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	177	Hospital	Hospital	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	178	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	179	kagawa	kagawa	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	180	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	181	8department	8department	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	182	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	183	Internal	Internal	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	184	Medicine	Medicine	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	185	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	186	fukuoka	fukuoka	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	187	Prefecture	Prefecture	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	188	yahata	yahata	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	189	general	general	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	190	Hospital	Hospital	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	191	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	192	9department	9department	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	193	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	194	Internal	Internal	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	195	Medicine	Medicine	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	196	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	197	fukuoka	fukuoka	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	198	saiseikai	saiseikai	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	199	Hospital	Hospital	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	200	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	201	fukuoka	fukuoka	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	21	202	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	203	Japan	Japan	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	204	Received	receive	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	205	April	April	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	206	15	15	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	207	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	208	2010	2010	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	209	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	210	Accepted	Accepted	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	211	June	June	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	212	18	18	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	213	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	214	2010	2010	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	215	dOI	doi	XX
work_5r5e7ca2zncbpm64fpccqjkzhi	21	216	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	217	10.3892	10.3892	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	218	/	/	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	21	219	ol_00000151	ol_00000151	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	220	Correspondence	Correspondence	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	221	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	21	222	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	223	dr	dr	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	224	Akira	Akira	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	225	Mizuki	Mizuki	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	226	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	227	department	department	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	228	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	229	Internal	Internal	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	230	Medicine	Medicine	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	231	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	232	saiseikai	saiseikai	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	233	Central	Central	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	234	Hospital	Hospital	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	235	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	236	Tokyo	Tokyo	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	237	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	238	Japan	Japan	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	239	E	E	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	240	-	-	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	241	mail	mail	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	242	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	243	amizuki@highway.ne.jp	amizuki@highway.ne.jp	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	244	Key	key	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	245	words	word	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	21	246	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	247	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	248	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	249	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	250	embolization	embolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	251	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	252	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	253	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	254	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	255	combination	combination	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	256	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	257	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	21	258	multicenter	multicenter	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	259	randomized	randomize	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	260	controlled	controlled	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	21	261	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	262	MIzukI	MIzukI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	263	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	264	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	265	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	21	266	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	267	ANd	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	21	268	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	21	269	COMBINATION	COMBINATION	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	270	THERAPy	THERAPy	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	21	271	AgAINsT	against	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	272	HCC856	HCC856	NNPS
work_5r5e7ca2zncbpm64fpccqjkzhi	21	273	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	21	274	range	range	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	21	275	from	from	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	276	14	14	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	277	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	21	278	44	44	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	279	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	21	280	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	21	281	7	7	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	282	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	21	283	10	10	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	21	284	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	21	285	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	22	1	Therefore	therefore	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	22	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	22	3	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	22	4	control	control	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	22	5	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	22	6	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	22	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	22	8	combination	combination	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	22	9	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	22	10	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	22	11	transcatheter	transcatheter	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	22	12	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	22	13	chemoembolization	chemoembolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	22	14	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	22	15	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	22	16	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	22	17	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	22	18	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	22	19	has	have	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	22	20	been	be	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	22	21	proposed	propose	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	22	22	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	23	1	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	23	2	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	23	3	widely	widely	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	23	4	used	use	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	23	5	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	23	6	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	23	7	considered	consider	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	23	8	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	23	9	be	be	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	23	10	an	an	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	23	11	effective	effective	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	23	12	conservative	conservative	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	23	13	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	23	14	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	23	15	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	23	16	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	24	1	Embolization	embolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	24	2	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	24	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	24	4	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	24	5	artery	artery	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	24	6	results	result	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	24	7	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	24	8	selective	selective	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	24	9	ischemic	ischemic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	24	10	necrosis	necrosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	24	11	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	24	12	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	24	13	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	24	14	tissue	tissue	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	24	15	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	24	16	11	11	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	24	17	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	24	18	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	25	1	However	however	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	25	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	25	3	complete	complete	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	25	4	necrosis	necrosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	25	5	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	25	6	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	25	7	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	25	8	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	25	9	embolization	embolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	25	10	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	25	11	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	25	12	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	25	13	artery	artery	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	25	14	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	25	15	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	25	16	almost	almost	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	25	17	impossible	impossible	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	25	18	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	25	19	achieve	achieve	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	25	20	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	25	21	12	12	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	25	22	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	25	23	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	26	1	A	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	26	2	number	number	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	26	3	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	26	4	clinical	clinical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	26	5	studies	study	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	26	6	examined	examine	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	26	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	26	8	non	non	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	26	9	-	-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	26	10	surgical	surgical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	26	11	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	26	12	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	26	13	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	26	14	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	26	15	including	include	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	26	16	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	26	17	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	26	18	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	26	19	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	26	20	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	26	21	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	26	22	combined	combined	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	26	23	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	26	24	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	26	25	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	26	26	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	26	27	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	26	28	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	26	29	13	13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	26	30	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	26	31	18	18	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	26	32	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	26	33	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	27	1	Certain	certain	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	27	2	inves-	inves-	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	27	3	tigators	tigator	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	27	4	reported	report	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	27	5	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	27	6	superior	superior	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	27	7	efficacy	efficacy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	27	8	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	27	9	combined	combined	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	27	10	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	27	11	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	27	12	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	27	13	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	27	14	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	27	15	compared	compare	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	27	16	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	27	17	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	27	18	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	27	19	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	28	1	koda	koda	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	28	2	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	28	3	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	28	4	attempted	attempt	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	28	5	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	28	6	clarify	clarify	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	28	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	28	8	efficacy	efficacy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	28	9	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	28	10	combination	combination	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	28	11	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	28	12	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	28	13	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	28	14	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	28	15	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	28	16	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	28	17	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	28	18	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	28	19	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	28	20	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	28	21	<3	<3	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	28	22	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	28	23	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	28	24	using	use	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	28	25	randomized	randomized	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	28	26	assign-	assign-	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	28	27	ment	ment	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	28	28	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	28	29	19	19	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	28	30	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	28	31	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	29	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	29	2	results	result	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	29	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	29	4	however	however	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	29	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	29	6	revealed	reveal	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	29	7	that	that	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	29	8	patient	patient	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	29	9	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	29	10	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	29	11	not	not	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	29	12	different	different	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	29	13	between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	29	14	combined	combined	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	29	15	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	29	16	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	29	17	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	29	18	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	29	19	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	29	20	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	29	21	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	29	22	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	29	23	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	30	1	stratified	stratified	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	30	2	analysis	analysis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	30	3	showed	show	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	30	4	that	that	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	30	5	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	30	6	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	30	7	bearing	bear	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	30	8	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	30	9	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	30	10	<	<	XX
work_5r5e7ca2zncbpm64fpccqjkzhi	30	11	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	30	12	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	30	13	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	30	14	combined	combine	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	30	15	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	30	16	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	30	17	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	30	18	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	30	19	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	30	20	superior	superior	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	30	21	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	30	22	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	30	23	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	30	24	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	31	1	Consequently	consequently	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	31	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	31	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	31	4	efficacy	efficacy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	31	5	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	31	6	additional	additional	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	31	7	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	31	8	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	31	9	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	31	10	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	31	11	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	31	12	recommended	recommend	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	31	13	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	31	14	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	31	15	HCCs	HCCs	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	31	16	>	>	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	31	17	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	31	18	cm	cm	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	31	19	has	have	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	31	20	yet	yet	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	31	21	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	31	22	be	be	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	31	23	determined	determine	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	31	24	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	32	1	Thus	thus	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	32	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	32	3	using	use	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	32	4	multicenter	multicenter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	5	randomized	randomize	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	6	assignment	assignment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	32	8	this	this	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	32	9	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	10	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	32	11	conducted	conduct	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	12	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	32	13	examine	examine	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	32	14	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	32	15	efficacy	efficacy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	16	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	17	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	32	18	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	32	19	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	32	20	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	21	instead	instead	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	32	22	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	23	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	32	24	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	32	25	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	26	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	32	27	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	28	relatively	relatively	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	32	29	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	32	30	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	32	31	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	32	32	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	32	33	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	32	34	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	32	35	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	32	36	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	32	37	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	38	diameter	diameter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	32	39	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	33	1	Patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	33	2	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	33	3	methods	method	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	33	4	Study	Study	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	33	5	design	design	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	33	6	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	34	1	This	this	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	34	2	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	34	3	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	34	4	multicenter	multicenter	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	34	5	randomized	randomized	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	34	6	control	control	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	34	7	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	34	8	RCT	RCT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	34	9	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	34	10	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	34	11	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	35	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	35	2	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	35	3	protocol	protocol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	35	4	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	35	5	approved	approve	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	35	6	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	35	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	35	8	review	review	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	35	9	board	board	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	35	10	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	35	11	each	each	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	35	12	hospital	hospital	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	35	13	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	35	14	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	35	15	all	all	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	35	16	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	35	17	provided	provide	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	35	18	informed	informed	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	35	19	written	written	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	35	20	consent	consent	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	35	21	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	36	1	Patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	36	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	37	1	Between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	37	2	July	July	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	37	3	1997	1997	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	37	4	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	37	5	April	April	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	37	6	1999	1999	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	37	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	37	8	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	37	9	diagnosed	diagnose	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	37	10	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	37	11	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	37	12	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	37	13	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	37	14	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	37	15	first	first	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	37	16	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	37	17	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	37	18	eligible	eligible	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	37	19	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	37	20	be	be	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	37	21	enrolled	enrol	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	37	22	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	37	23	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	37	24	subjects	subject	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	37	25	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	38	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	38	2	criteria	criterion	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	38	3	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	4	enrollment	enrollment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	5	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	6	this	this	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	38	7	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	8	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	38	9	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	38	10	i	i	PRP
work_5r5e7ca2zncbpm64fpccqjkzhi	38	11	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	38	12	age	age	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	13	<	<	XX
work_5r5e7ca2zncbpm64fpccqjkzhi	38	14	70	70	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	38	15	years	year	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	38	16	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	38	17	ii	ii	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	38	18	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	38	19	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	38	20	nodules	nodule	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	38	21	measuring	measure	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	38	22	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	38	23	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	38	24	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	38	25	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	38	26	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	27	maximum	maximum	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	38	28	diameter	diameter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	29	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	38	30	iii	iii	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	38	31	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	38	32	number	number	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	33	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	34	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	38	35	nodules	nodule	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	38	36	≤3	≤3	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	38	37	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	38	38	iv	iv	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	38	39	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	38	40	no	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	38	41	portal	portal	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	38	42	thrombosis	thrombosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	43	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	38	44	extrahepatic	extrahepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	38	45	metastasis	metastasis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	46	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	38	47	v	v	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	38	48	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	38	49	hypervascular	hypervascular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	38	50	nodules	nodule	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	38	51	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	38	52	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	53	determined	determine	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	54	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	55	dynamic	dynamic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	38	56	computed	computed	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	38	57	tomography	tomography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	58	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	38	59	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	38	60	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	38	61	scan	scan	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	38	62	and/or	and/or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	38	63	arteriography	arteriography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	64	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	38	65	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	38	66	vi	vi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	38	67	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	38	68	no	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	38	69	previous	previous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	38	70	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	71	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	72	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	38	73	prior	prior	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	38	74	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	75	entry	entry	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	38	76	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	39	1	Exclusion	exclusion	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	2	criteria	criterion	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	39	3	included	include	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	39	4	any	any	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	39	5	severe	severe	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	39	6	comorbidity	comorbidity	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	7	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	39	8	such	such	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	39	9	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	10	uncontrolled	uncontrolled	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	39	11	diabetes	diabetes	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	12	mellitus	mellitus	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	13	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	39	14	heart	heart	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	15	failure	failure	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	16	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	39	17	renal	renal	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	39	18	failure	failure	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	19	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	39	20	other	other	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	39	21	cancer	cancer	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	22	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	39	23	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	39	24	as	as	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	39	25	well	well	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	39	26	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	27	any	any	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	39	28	patient	patient	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	29	who	who	WP
work_5r5e7ca2zncbpm64fpccqjkzhi	39	30	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	39	31	unable	unable	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	39	32	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	39	33	understand	understand	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	39	34	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	39	35	protocol	protocol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	36	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	39	37	manage	manage	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	39	38	self	self	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	39	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	39	40	care	care	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	39	41	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	40	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	40	2	diagnosis	diagnosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	40	3	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	40	4	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	40	5	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	40	6	made	make	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	40	7	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	40	8	dynamic	dynamic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	40	9	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	40	10	and/	and/	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	40	11	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	40	12	abdominal	abdominal	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	40	13	sonography	sonography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	40	14	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	41	1	To	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	41	2	assist	assist	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	41	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	41	4	diagnosis	diagnosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	41	5	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	41	6	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	41	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	41	8	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	41	9	needle	needle	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	41	10	biopsy	biopsy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	41	11	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	41	12	performed	perform	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	41	13	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	41	14	all	all	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	41	15	27	27	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	41	16	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	41	17	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	42	1	Tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	42	2	vascu-	vascu-	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	42	3	larity	larity	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	42	4	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	42	5	also	also	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	42	6	evaluated	evaluate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	42	7	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	42	8	dynamic	dynamic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	42	9	CT	ct	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	42	10	and/or	and/or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	42	11	angiography	angiography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	42	12	from	from	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	42	13	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	42	14	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	42	15	artery	artery	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	42	16	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	43	1	Randomization	randomization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	43	2	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	43	3	performed	perform	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	43	4	using	use	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	43	5	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	43	6	sealed	seal	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	43	7	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	43	8	envelope	envelope	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	43	9	method	method	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	43	10	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	44	1	Patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	44	2	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	44	3	divided	divide	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	4	into	into	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	5	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	44	6	groups	group	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	44	7	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	44	8	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	44	9	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	44	10	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	44	11	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	44	12	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	13	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	44	14	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	15	which	which	WDT
work_5r5e7ca2zncbpm64fpccqjkzhi	44	16	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	44	17	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	44	18	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	19	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	20	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	44	21	followed	follow	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	22	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	23	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	44	24	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	44	25	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	44	26	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	44	27	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	44	28	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	44	29	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	30	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	44	31	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	32	which	which	WDT
work_5r5e7ca2zncbpm64fpccqjkzhi	44	33	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	44	34	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	44	35	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	36	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	37	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	44	38	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	44	39	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	44	40	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	45	1	Treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	45	2	procedure	procedure	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	45	3	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	46	1	Patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	46	2	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	46	3	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	46	4	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	46	5	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	46	6	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	46	7	trained	train	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	46	8	specialists	specialist	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	46	9	at	at	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	46	10	each	each	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	46	11	institution	institution	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	46	12	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	47	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	47	2	precise	precise	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	47	3	techniques	technique	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	47	4	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	47	5	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	47	6	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	47	7	are	be	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	47	8	described	describe	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	47	9	elsewhere	elsewhere	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	47	10	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	47	11	7	7	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	47	12	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	47	13	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	48	1	Briefly	briefly	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	48	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	48	3	after	after	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	48	4	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	48	5	anesthesia	anesthesia	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	48	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	48	7	one	one	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	48	8	21-gauge	21-gauge	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	48	9	needle	needle	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	48	10	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	48	11	inserted	insert	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	48	12	into	into	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	48	13	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	48	14	lesion	lesion	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	48	15	under	under	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	48	16	ultrasound	ultrasound	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	48	17	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	48	18	us	us	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	48	19	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	48	20	guidance	guidance	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	48	21	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	48	22	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	48	23	absolute	absolute	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	48	24	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	48	25	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	48	26	injected	inject	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	48	27	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	49	1	In	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	2	one	one	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	49	3	session	session	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	4	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	49	5	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	49	6	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	49	7	8	8	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	49	8	ml	ml	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	9	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	10	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	11	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	49	12	injected	inject	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	13	into	into	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	14	several	several	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	49	15	sites	site	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	49	16	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	17	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	49	18	around	around	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	19	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	49	20	lesion	lesion	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	21	according	accord	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	49	22	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	23	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	49	24	lesion	lesion	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	25	size	size	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	49	26	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	50	1	After	after	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	50	2	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	50	3	procedure	procedure	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	50	4	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	50	5	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	50	6	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	50	7	remained	remain	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	50	8	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	50	9	bed	bed	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	50	10	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	50	11	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	50	12	h.	h.	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	50	13	This	this	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	50	14	procedure	procedure	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	50	15	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	50	16	performed	perform	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	50	17	twice	twice	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	50	18	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	50	19	week	week	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	50	20	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	51	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	51	2	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	51	3	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	51	4	repeated	repeat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	51	5	until	until	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	51	6	dynamic	dynamic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	51	7	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	51	8	demonstrated	demonstrate	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	51	9	entire	entire	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	51	10	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	51	11	necrosis	necrosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	51	12	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	52	1	In	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	52	2	addition	addition	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	52	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	52	4	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	52	5	[	[	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	52	6	precise	precise	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	52	7	techniques	technique	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	52	8	are	be	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	52	9	described	describe	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	52	10	else-	else-	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	52	11	where	where	WRB
work_5r5e7ca2zncbpm64fpccqjkzhi	52	12	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	52	13	12,13	12,13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	52	14	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	52	15	]	]	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	52	16	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	52	17	performed	perform	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	52	18	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	52	19	super	super	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	52	20	-	-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	52	21	selectively	selectively	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	52	22	introducing	introduce	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	52	23	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	52	24	catheter	catheter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	52	25	into	into	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	52	26	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	52	27	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	52	28	artery	artery	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	52	29	that	that	WDT
work_5r5e7ca2zncbpm64fpccqjkzhi	52	30	fed	feed	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	52	31	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	52	32	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	52	33	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	53	1	A	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	53	2	mixture	mixture	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	3	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	4	an	an	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	53	5	ionized	ionized	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	53	6	oil	oil	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	7	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	53	8	doxorubicin	doxorubicin	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	53	9	hydrochloride	hydrochloride	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	53	10	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	53	11	0.6	0.6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	53	12	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	53	13	1.0	1.0	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	53	14	mg	mg	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	53	15	per	per	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	16	kg	kg	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	53	17	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	18	body	body	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	19	weight	weight	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	20	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	53	21	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	53	22	injected	inject	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	23	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	53	24	followed	follow	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	25	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	26	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	53	27	gelatin	gelatin	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	28	sponge	sponge	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	53	29	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	54	1	diagnosis	diagnosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	54	2	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	54	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	54	4	remaining	remain	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	54	5	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	54	6	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	54	7	based	base	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	54	8	on	on	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	54	9	image	image	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	54	10	findings	finding	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	54	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	54	12	particularly	particularly	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	54	13	dynamic	dynamic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	54	14	CT	CT	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	54	15	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	55	1	In	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	2	addition	addition	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	55	4	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	55	5	positivity	positivity	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	6	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	7	serum	serum	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	55	8	α	α	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	55	9	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	55	10	fetoprotein	fetoprotein	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	55	11	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	55	12	AfP	AfP	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	55	13	>	>	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	55	14	10	10	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	55	15	ng	ng	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	16	/	/	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	55	17	ml	ml	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	18	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	55	19	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	55	20	serum	serum	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	21	protein	protein	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	22	induced	induce	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	23	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	24	vitamin	vitamin	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	25	k	k	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	55	26	absence	absence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	27	II	II	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	55	28	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	55	29	PIVkA	PIVkA	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	55	30	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	55	31	II	ii	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	55	32	>	>	XX
work_5r5e7ca2zncbpm64fpccqjkzhi	55	33	40	40	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	55	34	mAu	mAu	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	55	35	/	/	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	55	36	ml	ml	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	55	37	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	55	38	facilitated	facilitate	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	55	39	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	55	40	diagnosis	diagnosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	55	41	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	56	1	Follow	follow	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	56	2	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	56	3	up	up	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	56	4	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	57	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	57	2	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	57	3	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	57	4	under	under	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	57	5	regular	regular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	57	6	observation	observation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	57	7	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	57	8	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	57	9	detection	detection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	57	10	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	57	11	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	57	12	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	57	13	measurement	measurement	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	57	14	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	57	15	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	57	16	markers	marker	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	57	17	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	57	18	AfP	AfP	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	57	19	and/or	and/or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	57	20	PIVkA	PIVkA	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	57	21	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	57	22	II	II	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	57	23	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	57	24	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	57	25	ultrasonography	ultrasonography	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	57	26	and/or	and/or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	57	27	dynamic	dynamic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	57	28	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	57	29	scans	scan	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	57	30	every	every	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	57	31	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	57	32	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	57	33	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	58	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	58	2	primary	primary	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	58	3	endpoint	endpoint	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	58	4	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	58	5	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	58	6	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	58	7	indicated	indicate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	58	8	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	58	9	any	any	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	58	10	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	58	11	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	58	12	above	above	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	58	13	examinations	examination	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	58	14	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	59	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	59	2	secondary	secondary	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	59	3	endpoint	endpoint	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	59	4	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	59	5	patient	patient	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	59	6	death	death	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	59	7	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	60	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	60	2	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	60	3	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	60	4	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	60	5	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	60	6	clas-	clas-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	60	7	sified	sified	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	60	8	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	60	9	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	60	10	residual	residual	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	60	11	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	60	12	new	new	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	60	13	nodular	nodular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	60	14	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	60	15	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	60	16	lesions	lesion	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	60	17	other	other	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	60	18	than	than	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	60	19	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	60	20	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	60	21	treated	treat	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	60	22	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	61	1	Local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	61	2	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	61	3	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	61	4	defined	define	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	61	5	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	61	6	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	61	7	within	within	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	61	8	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	61	9	adjacent	adjacent	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	61	10	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	61	11	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	61	12	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	61	13	being	be	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	61	14	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	61	15	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	62	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	62	2	recurrent	recurrent	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	62	3	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	62	4	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	62	5	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	62	6	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	62	7	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	62	8	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	62	9	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	62	10	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	62	11	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	62	12	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	63	1	In	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	63	2	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	63	3	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	63	4	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	63	5	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	63	6	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	63	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	63	8	however	however	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	63	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	63	10	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	63	11	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	63	12	performed	perform	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	63	13	when	when	WRB
work_5r5e7ca2zncbpm64fpccqjkzhi	63	14	≥3	≥3	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	63	15	recurrent	recurrent	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	63	16	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	63	17	developed	develop	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	63	18	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	64	1	Statistical	statistical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	64	2	analysis	analysis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	64	3	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	65	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	65	2	statistical	statistical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	65	3	significance	significance	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	65	4	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	65	5	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	65	6	patient	patient	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	65	7	characteristics	characteristic	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	65	8	between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	65	9	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	65	10	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	65	11	groups	group	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	65	12	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	65	13	determined	determine	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	65	14	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	65	15	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	65	16	Chi	Chi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	65	17	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	65	18	square	square	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	65	19	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	65	20	Mann	Mann	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	65	21	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	65	22	Whitney	Whitney	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	65	23	u	u	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	65	24	test	test	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	65	25	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	66	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	66	2	mean	mean	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	66	3	cancer	cancer	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	66	4	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	66	5	free	free	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	66	6	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	66	7	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	66	8	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	66	9	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	66	10	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	66	11	calculated	calculate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	66	12	using	use	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	66	13	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	66	14	kaplan	kaplan	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	66	15	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	66	16	Meier	Meier	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	66	17	method	method	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	66	18	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	66	19	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	66	20	significance	significance	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	66	21	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	66	22	determined	determine	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	66	23	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	66	24	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	66	25	generalized	generalize	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	66	26	Wilcoxon	Wilcoxon	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	66	27	's	's	POS
work_5r5e7ca2zncbpm64fpccqjkzhi	66	28	test	test	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	66	29	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	67	1	P<0.05	P<0.05	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	67	2	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	67	3	considered	consider	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	67	4	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	67	5	be	be	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	67	6	significant	significant	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	67	7	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	68	1	Results	result	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	68	2	A	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	68	3	total	total	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	68	4	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	68	5	30	30	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	68	6	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	68	7	fulfilled	fulfil	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	68	8	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	68	9	criteria	criterion	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	68	10	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	68	11	enrollment	enrollment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	68	12	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	68	13	this	this	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	68	14	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	68	15	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	69	1	Patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	69	2	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	69	3	stratified	stratify	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	69	4	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	69	5	randomized	randomize	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	69	6	into	into	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	69	7	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	69	8	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	69	9	arms	arm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	69	10	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	69	11	16	16	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	69	12	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	69	13	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	69	14	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	69	15	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	69	16	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	69	17	combination	combination	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	69	18	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	69	19	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	69	20	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	69	21	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	69	22	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	69	23	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	69	24	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	69	25	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	69	26	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	69	27	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	69	28	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	69	29	14	14	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	69	30	received	receive	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	69	31	only	only	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	69	32	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	69	33	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	69	34	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	69	35	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	69	36	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	69	37	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	69	38	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	69	39	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	69	40	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	70	1	However	however	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	70	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	70	3	three	three	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	70	4	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	70	5	withdrew	withdraw	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	70	6	from	from	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	70	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	70	8	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	70	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	70	10	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	70	11	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	70	12	final	final	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	70	13	number	number	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	70	14	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	70	15	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	70	16	analyzed	analyze	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	70	17	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	70	18	27	27	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	70	19	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	70	20	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	70	21	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	70	22	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	70	23	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	70	24	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	70	25	13	13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	70	26	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	70	27	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	70	28	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	70	29	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	70	30	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	70	31	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	70	32	14	14	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	70	33	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	70	34	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	71	1	Of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	71	2	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	71	3	27	27	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	71	4	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	71	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	71	6	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	71	7	had	have	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	71	8	cirrhosis	cirrhosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	71	9	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	71	10	23	23	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	71	11	had	have	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	71	12	chronic	chronic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	71	13	hepatitis	hepatitis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	71	14	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	72	1	Hepatitis	Hepatitis	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	72	2	B	B	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	72	3	surface	surface	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	72	4	antigen	antigen	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	72	5	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	72	6	positive	positive	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	72	7	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	72	8	5	5	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	72	9	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	72	10	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	72	11	27	27	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	72	12	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	72	13	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	72	14	18.5	18.5	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	72	15	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	72	16	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	72	17	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	72	18	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	72	19	HCV	HCV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	72	20	antibody	antibody	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	72	21	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	72	22	positive	positive	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	72	23	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	72	24	20	20	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	72	25	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	72	26	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	72	27	27	27	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	72	28	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	72	29	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	72	30	74.1	74.1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	72	31	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	72	32	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	72	33	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	73	1	No	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	73	2	significant	significant	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	73	3	differences	difference	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	73	4	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	73	5	noted	note	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	73	6	between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	73	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	73	8	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	73	9	groups	group	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	73	10	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	73	11	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	73	12	baseline	baseline	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	73	13	characteristics	characteristic	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	73	14	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	73	15	Table	table	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	73	16	I	I	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	73	17	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	73	18	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	74	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	74	2	median	median	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	74	3	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	74	4	interquartile	interquartile	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	74	5	range	range	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	74	6	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	74	7	follow	follow	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	74	8	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	74	9	up	up	RP
work_5r5e7ca2zncbpm64fpccqjkzhi	74	10	period	period	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	74	11	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	74	12	33.2	33.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	74	13	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	74	14	24.6	24.6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	74	15	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	74	16	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	74	17	[	[	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	74	18	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	74	19	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	74	20	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	74	21	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	74	22	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	74	23	39.7	39.7	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	74	24	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	74	25	46.7	46.7	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	74	26	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	74	27	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	74	28	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	74	29	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	74	30	alone	alone	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	74	31	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	74	32	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	74	33	33	33	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	74	34	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	74	35	42.7	42.7	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	74	36	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	74	37	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	74	38	]	]	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	74	39	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	75	1	Primary	primary	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	75	2	endpoint	endpoint	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	75	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	75	4	Recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	75	5	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	76	1	Tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	76	2	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	76	3	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	76	4	detected	detect	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	76	5	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	76	6	10	10	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	76	7	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	76	8	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	76	9	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	76	10	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	76	11	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	76	12	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	76	13	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	76	14	11	11	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	76	15	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	76	16	ONCOLOGY	ONCOLOGY	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	76	17	LETTERS	letter	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	76	18	1	1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	76	19	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	76	20	855	855	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	76	21	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	76	22	859	859	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	76	23	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	76	24	2010	2010	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	76	25	857	857	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	76	26	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	76	27	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	76	28	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	76	29	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	76	30	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	76	31	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	77	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	77	2	cumulative	cumulative	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	77	3	cancer	cancer	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	77	4	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	77	5	free	free	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	77	6	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	77	7	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	77	8	calculated	calculate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	77	9	using	use	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	77	10	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	77	11	kaplan	kaplan	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	77	12	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	77	13	Meier	Meier	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	77	14	method	method	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	77	15	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	77	16	fig	fig	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	77	17	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	78	1	1	1	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	78	2	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	78	3	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	79	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	79	2	mean	mean	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	79	3	cancer	cancer	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	79	4	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	79	5	free	free	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	79	6	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	79	7	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	79	8	16.7	16.7	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	79	9	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	79	10	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	79	11	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	79	12	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	79	13	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	79	14	7.3	7.3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	79	15	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	79	16	26.0	26.0	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	79	17	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	79	18	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	79	19	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	79	20	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	79	21	alone	alone	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	79	22	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	79	23	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	79	24	22.9	22.9	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	79	25	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	79	26	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	79	27	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	79	28	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	79	29	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	79	30	12.4	12.4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	79	31	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	79	32	33.4	33.4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	79	33	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	79	34	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	79	35	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	79	36	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	79	37	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	79	38	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	79	39	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	79	40	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	80	1	No	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	80	2	significant	significant	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	80	3	difference	difference	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	80	4	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	80	5	found	find	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	80	6	between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	80	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	80	8	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	80	9	groups	group	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	80	10	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	81	1	However	however	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	81	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	81	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	81	4	pattern	pattern	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	81	5	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	81	6	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	81	7	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	81	8	significantly	significantly	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	81	9	different	different	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	81	10	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	81	11	P<0.05	p<0.05	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	81	12	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	81	13	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	82	1	during	during	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	2	follow	follow	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	3	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	82	4	up	up	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	82	6	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	82	7	detec-	detec-	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	82	8	tion	tion	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	9	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	10	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	82	11	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	82	12	residual	residual	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	82	13	lesion	lesion	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	14	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	82	15	observed	observe	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	16	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	17	1	1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	82	18	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	19	13	13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	82	20	nodules	nodule	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	82	21	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	82	22	7.6	7.6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	82	23	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	24	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	82	25	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	26	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	82	27	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	82	28	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	82	29	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	82	30	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	31	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	82	32	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	33	6	6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	82	34	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	35	13	13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	82	36	nodules	nodule	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	82	37	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	82	38	46.1	46.1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	82	39	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	40	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	82	41	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	42	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	82	43	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	82	44	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	82	45	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	82	46	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	82	47	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	83	1	No	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	83	2	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	83	3	residual	residual	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	83	4	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	83	5	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	83	6	detected	detect	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	83	7	after	after	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	83	8	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	83	9	years	year	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	83	10	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	83	11	follow	follow	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	83	12	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	83	13	up	up	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	83	14	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	83	15	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	83	16	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	83	17	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	83	18	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	83	19	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	83	20	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	84	1	On	on	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	2	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	84	3	other	other	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	84	4	hand	hand	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	84	6	new	new	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	84	7	nodular	nodular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	84	8	recurrences	recurrence	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	84	9	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	84	10	observed	observe	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	11	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	12	8	8	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	84	13	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	14	13	13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	84	15	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	84	16	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	84	17	61.5	61.5	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	84	18	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	19	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	84	20	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	21	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	84	22	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	84	23	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	84	24	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	84	25	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	26	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	84	27	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	28	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	84	29	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	30	14	14	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	84	31	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	84	32	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	84	33	21.4	21.4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	84	34	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	35	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	84	36	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	37	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	84	38	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	84	39	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	84	40	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	84	41	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	84	42	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	85	1	Secondary	secondary	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	85	2	endpoint	endpoint	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	85	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	85	4	Death	death	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	85	5	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	86	1	Of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	2	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	86	3	13	13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	86	4	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	86	5	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	86	6	61.5	61.5	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	86	7	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	8	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	86	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	86	10	8	8	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	86	11	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	12	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	13	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	86	14	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	86	15	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	86	16	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	86	17	6	6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	86	18	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	19	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	86	20	14	14	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	86	21	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	86	22	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	86	23	44	44	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	86	24	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	25	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	86	26	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	27	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	28	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	86	29	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	86	30	succumbed	succumb	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	86	31	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	32	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	86	33	disease	disease	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	34	during	during	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	35	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	86	36	Table	table	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	86	37	I.	i.	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	87	1	Clinical	clinical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	87	2	characteristics	characteristic	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	87	3	according	accord	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	87	4	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	87	5	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	87	6	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	87	7	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	87	8	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	88	1	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	2	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	3	n=14	n=14	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	4	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	5	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	6	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	88	7	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	8	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	9	n=13	n=13	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	10	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	11	P	p	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	12	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	88	13	value	value	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	14	Age	age	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	15	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	16	years	year	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	88	17	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	18	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	19	mean	mean	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	88	20	±	±	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	21	sd	sd	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	22	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	23	63.6±6.2	63.6±6.2	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	24	65.8±7.3	65.8±7.3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	25	Ns	ns	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	26	gender	gender	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	27	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	28	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	29	/	/	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	88	30	f	f	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	31	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	32	7/7	7/7	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	33	9/4	9/4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	34	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	35	Etiology	Etiology	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	36	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	37	liver	liver	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	38	disease	disease	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	39	HBV	HBV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	40	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	41	0	0	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	42	HCV	HCV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	43	9	9	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	44	9	9	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	45	HBV	HBV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	46	+	+	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	88	47	HCV	HCV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	48	1	1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	49	1	1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	50	NBNC	nbnc	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	51	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	52	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	53	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	54	Chronic	Chronic	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	55	hepatitis	hepatitis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	56	13	13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	57	10	10	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	58	Cirrhosis	cirrhosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	59	1	1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	60	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	61	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	62	Albumin	Albumin	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	63	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	64	g	g	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	65	/	/	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	88	66	dl	dl	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	67	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	68	3.5±0.3	3.5±0.3	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	69	3.8±0.4	3.8±0.4	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	70	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	71	Total	total	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	88	72	bilirubin	bilirubin	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	73	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	74	mg	mg	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	75	/	/	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	88	76	dl	dl	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	77	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	78	1.1±0.6	1.1±0.6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	79	1.2±0.8	1.2±0.8	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	80	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	81	ALT	ALT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	82	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	83	uI	uI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	84	/	/	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	88	85	l	l	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	86	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	87	82±50	82±50	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	88	145±99	145±99	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	89	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	90	AsT	ast	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	91	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	92	uI	uI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	93	/	/	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	88	94	l	l	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	95	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	96	65±53	65±53	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	97	129±65	129±65	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	98	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	99	Prothrombin	Prothrombin	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	100	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	101	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	102	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	103	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	104	63±3.6	63±3.6	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	105	77±15	77±15	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	106	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	107	α	α	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	108	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	88	109	fetoprotein	fetoprotein	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	110	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	111	ng	ng	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	112	/	/	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	88	113	ml	ml	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	114	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	115	[	[	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	116	median	median	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	117	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	118	range	range	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	119	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	120	]	]	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	121	13	13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	122	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	123	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	124	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	88	125	97	97	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	126	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	127	16	16	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	128	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	129	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	130	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	88	131	373	373	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	132	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	133	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	134	Tumor	Tumor	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	135	lesions	lesion	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	88	136	single	single	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	88	137	nodule	nodule	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	138	11	11	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	139	8	8	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	140	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	141	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	88	142	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	143	nodules	nodule	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	88	144	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	145	5	5	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	146	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	147	greatest	great	JJS
work_5r5e7ca2zncbpm64fpccqjkzhi	88	148	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	149	dimension	dimension	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	150	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	151	mm	mm	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	152	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	88	153	26.4±7.4	26.4±7.4	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	154	26.5±6.8	26.5±6.8	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	88	155	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	156	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	157	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	88	158	transcatheter	transcatheter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	159	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	88	160	chemoembolization	chemoembolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	161	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	88	162	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	163	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	88	164	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	88	165	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	166	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	167	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	88	168	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	169	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	88	170	male	male	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	171	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	88	172	f	f	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	88	173	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	88	174	female	female	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	88	175	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	88	176	Ns	Ns	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	177	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	88	178	not	not	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	88	179	significant	significant	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	88	180	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	88	181	HBV	HBV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	182	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	88	183	hepatitis	hepatitis	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	184	B	B	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	185	virus	virus	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	186	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	88	187	HCV	HCV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	188	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	88	189	hepatitis	hepatitis	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	190	C	C	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	191	virus	virus	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	192	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	88	193	NBNC	NBNC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	194	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	88	195	non	non	AFX
work_5r5e7ca2zncbpm64fpccqjkzhi	88	196	HBV	HBV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	197	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	88	198	non	non	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	199	HCV	HCV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	200	;	;	:
work_5r5e7ca2zncbpm64fpccqjkzhi	88	201	ALT	ALT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	202	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	88	203	alanine	alanine	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	204	aminotransferase	aminotransferase	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	205	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	88	206	AsT	AsT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	88	207	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	88	208	aspartate	aspartate	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	209	aminotransferase	aminotransferase	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	88	210	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	89	1	figure	figure	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	89	2	1	1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	89	3	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	90	1	Comparison	comparison	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	90	2	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	90	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	90	4	cumulative	cumulative	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	90	5	cancer	cancer	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	90	6	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	90	7	free	free	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	90	8	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	90	9	between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	90	10	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	90	11	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	90	12	that	that	WDT
work_5r5e7ca2zncbpm64fpccqjkzhi	90	13	received	receive	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	90	14	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	90	15	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	90	16	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	90	17	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	90	18	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	90	19	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	90	20	that	that	WDT
work_5r5e7ca2zncbpm64fpccqjkzhi	90	21	received	receive	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	90	22	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	90	23	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	90	24	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	90	25	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	91	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	91	2	mean	mean	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	91	3	cancer	cancer	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	91	4	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	91	5	free	free	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	91	6	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	91	7	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	91	8	16.7	16.7	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	91	9	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	91	10	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	91	11	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	91	12	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	91	13	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	91	14	7.3	7.3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	91	15	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	91	16	26.0	26.0	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	91	17	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	91	18	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	91	19	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	91	20	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	91	21	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	91	22	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	91	23	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	91	24	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	91	25	22.9	22.9	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	91	26	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	91	27	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	91	28	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	91	29	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	91	30	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	91	31	12.4	12.4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	91	32	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	91	33	33.4	33.4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	91	34	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	91	35	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	91	36	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	91	37	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	91	38	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	91	39	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	91	40	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	91	41	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	92	1	No	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	92	2	significant	significant	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	92	3	difference	difference	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	92	4	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	92	5	noted	note	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	92	6	between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	92	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	92	8	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	92	9	groups	group	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	92	10	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	93	1	figure	figure	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	93	2	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	93	3	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	94	1	Comparison	comparison	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	94	2	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	94	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	94	4	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	94	5	rates	rate	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	94	6	between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	94	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	94	8	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	94	9	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	94	10	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	94	11	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	94	12	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	94	13	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	94	14	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	94	15	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	94	16	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	94	17	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	94	18	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	95	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	95	2	mean	mean	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	95	3	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	95	4	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	95	5	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	95	6	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	95	7	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	95	8	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	95	9	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	95	10	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	95	11	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	95	12	42.4	42.4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	95	13	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	95	14	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	95	15	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	95	16	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	95	17	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	95	18	29.2	29.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	95	19	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	95	20	55.6	55.6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	95	21	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	95	22	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	95	23	that	that	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	95	24	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	95	25	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	95	26	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	95	27	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	95	28	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	95	29	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	95	30	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	95	31	57.2	57.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	95	32	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	95	33	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	95	34	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	95	35	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	95	36	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	95	37	37.2	37.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	95	38	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	95	39	77.2	77.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	95	40	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	95	41	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	96	1	No	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	96	2	significant	significant	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	96	3	difference	difference	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	96	4	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	96	5	found	find	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	96	6	between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	96	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	96	8	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	96	9	groups	group	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	96	10	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	97	1	MIzukI	MIzukI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	97	2	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	97	3	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	97	4	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	97	5	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	97	6	ANd	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	97	7	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	97	8	COMBINATION	COMBINATION	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	97	9	THERAPy	THERAPy	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	97	10	AgAINsT	against	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	97	11	HCC858	HCC858	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	97	12	follow	follow	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	97	13	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	97	14	up	up	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	97	15	period	period	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	97	16	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	98	1	In	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	98	2	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	98	3	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	98	4	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	98	5	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	98	6	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	98	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	98	8	causes	cause	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	98	9	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	98	10	death	death	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	98	11	included	include	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	98	12	development	development	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	98	13	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	98	14	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	98	15	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	98	16	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	98	17	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	98	18	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	98	19	variceral	variceral	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	98	20	bleeding	bleeding	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	98	21	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	98	22	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	98	23	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	98	24	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	98	25	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	98	26	failure	failure	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	98	27	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	98	28	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	98	29	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	98	30	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	99	1	In	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	2	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	99	3	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	99	4	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	99	5	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	99	6	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	99	8	causes	cause	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	99	9	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	10	death	death	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	11	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	99	12	development	development	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	13	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	14	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	99	15	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	16	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	99	17	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	99	18	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	99	19	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	99	20	failure	failure	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	21	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	22	3	3	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	99	23	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	99	24	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	99	25	other	other	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	99	26	diseases	disease	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	99	27	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	99	28	tuberculosis	tuberculosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	29	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	99	30	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	31	1	1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	99	32	patient	patient	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	99	33	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	100	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	100	2	cumulative	cumulative	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	100	3	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	100	4	curves	curve	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	100	5	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	100	6	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	100	7	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	100	8	groups	group	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	100	9	are	be	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	100	10	shown	show	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	100	11	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	100	12	fig	fig	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	100	13	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	101	1	2	2	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	101	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	102	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	102	2	mean	mean	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	102	3	patient	patient	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	102	4	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	102	5	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	102	6	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	102	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	102	8	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	102	9	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	102	10	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	102	11	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	102	12	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	102	13	42.4	42.4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	102	14	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	102	15	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	102	16	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	102	17	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	102	18	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	102	19	29.2	29.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	102	20	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	102	21	55.6	55.6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	102	22	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	102	23	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	102	24	that	that	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	102	25	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	102	26	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	102	27	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	102	28	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	102	29	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	102	30	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	102	31	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	102	32	57.2	57.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	102	33	months	month	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	102	34	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	102	35	95	95	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	102	36	%	%	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	102	37	CI	CI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	102	38	37.2	37.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	102	39	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	102	40	77.2	77.2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	102	41	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	102	42	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	103	1	No	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	103	2	significant	significant	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	103	3	difference	difference	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	103	4	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	103	5	noted	note	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	103	6	between	between	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	103	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	103	8	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	103	9	groups	group	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	103	10	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	104	1	Adverse	adverse	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	104	2	events	event	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	104	3	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	105	1	In	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	2	all	all	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	105	3	30	30	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	105	4	cases	case	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	105	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	105	6	serious	serious	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	105	7	adverse	adverse	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	105	8	effects	effect	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	105	9	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	105	10	complications	complication	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	105	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	105	12	such	such	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	105	13	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	14	acute	acute	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	105	15	liver	liver	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	16	failure	failure	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	17	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	105	18	liver	liver	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	19	infarction	infarction	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	20	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	105	21	abscess	abscess	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	22	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	105	23	cholecystitis	cholecystitis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	24	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	105	25	gastrointestinal	gastrointestinal	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	105	26	mucosal	mucosal	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	27	lesions	lesion	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	105	28	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	105	29	pulmonary	pulmonary	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	105	30	embolism	embolism	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	31	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	105	32	variceral	variceral	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	105	33	bleeding	bleeding	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	34	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	105	35	iatrogenic	iatrogenic	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	36	dissec-	dissec-	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	37	tion	tion	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	38	or	or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	105	39	perforation	perforation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	40	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	41	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	105	42	celiac	celiac	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	105	43	artery	artery	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	44	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	105	45	its	-PRON-	PRP$
work_5r5e7ca2zncbpm64fpccqjkzhi	105	46	branches	branch	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	105	47	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	105	48	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	105	49	not	not	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	105	50	related	relate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	51	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	52	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	53	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	105	54	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	105	55	and/or	and/or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	105	56	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	105	57	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	106	1	Discussion	Discussion	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	106	2	This	this	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	106	3	RCT	RCT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	106	4	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	5	failed	fail	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	106	6	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	106	7	show	show	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	106	8	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	106	9	anticipated	anticipate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	10	efficacy	efficacy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	11	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	12	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	106	13	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	106	14	PET	PET	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	106	15	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	16	compared	compare	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	17	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	18	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	106	19	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	20	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	106	21	on	on	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	22	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	23	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	24	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	25	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	106	26	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	27	relatively	relatively	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	106	28	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	106	29	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	106	30	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	31	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	106	32	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	106	33	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	106	34	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	106	35	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	36	diameter	diameter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	106	37	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	107	1	Together	together	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	107	2	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	107	4	previous	previous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	107	5	RCT	RCT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	107	6	result	result	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	7	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	8	koda	koda	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	107	9	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	107	10	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	107	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	107	12	it	-PRON-	PRP
work_5r5e7ca2zncbpm64fpccqjkzhi	107	13	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	107	14	found	find	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	15	that	that	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	16	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	107	17	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	18	size	size	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	19	smaller	small	JJR
work_5r5e7ca2zncbpm64fpccqjkzhi	107	20	than	than	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	21	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	107	22	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	107	23	may	may	MD
work_5r5e7ca2zncbpm64fpccqjkzhi	107	24	be	be	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	107	25	critical	critical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	107	26	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	27	obtaining	obtain	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	107	28	significant	significant	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	107	29	effectiveness	effectiveness	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	30	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	31	combining	combine	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	107	32	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	107	33	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	34	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	107	35	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	107	36	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	107	37	19	19	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	107	38	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	107	39	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	108	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	108	2	present	present	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	108	3	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	108	4	showed	show	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	108	5	marked	marked	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	108	6	differences	difference	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	108	7	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	108	8	recur-	recur-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	108	9	rence	rence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	108	10	patterns	pattern	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	108	11	after	after	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	108	12	initial	initial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	108	13	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	108	14	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	109	1	Our	-PRON-	PRP$
work_5r5e7ca2zncbpm64fpccqjkzhi	109	2	results	result	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	109	3	indicate	indicate	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	109	4	that	that	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	109	5	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	109	6	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	109	7	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	109	8	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	109	9	superior	superior	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	109	10	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	109	11	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	109	12	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	109	13	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	109	14	regarding	regard	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	109	15	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	109	16	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	109	17	control	control	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	109	18	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	110	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	110	2	addition	addition	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	110	3	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	110	4	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	110	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	110	6	however	however	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	110	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	110	8	evoked	evoke	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	110	9	new	new	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	110	10	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	110	11	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	110	12	different	different	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	110	13	lesions	lesion	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	110	14	other	other	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	110	15	than	than	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	110	16	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	110	17	original	original	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	110	18	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	110	19	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	111	1	We	-PRON-	PRP
work_5r5e7ca2zncbpm64fpccqjkzhi	111	2	believe	believe	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	111	3	that	that	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	4	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	111	5	induction	induction	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	6	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	7	growth	growth	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	8	factors	factor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	111	9	such	such	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	111	10	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	11	VEgf	VEgf	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	111	12	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	111	13	Hgf	Hgf	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	111	14	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	111	15	20	20	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	111	16	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	111	17	23	23	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	111	18	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	111	19	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	111	20	due	due	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	21	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	22	ischemia	ischemia	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	23	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	24	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	111	25	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	111	26	are	be	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	111	27	involved	involve	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	28	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	29	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	111	30	development	development	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	31	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	111	32	new	new	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	111	33	nodules	nodule	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	111	34	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	112	1	A	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	112	2	liver	liver	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	112	3	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	112	4	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	112	5	larger	large	JJR
work_5r5e7ca2zncbpm64fpccqjkzhi	112	6	than	than	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	112	7	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	112	8	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	112	9	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	112	10	diameter	diameter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	112	11	may	may	MD
work_5r5e7ca2zncbpm64fpccqjkzhi	112	12	be	be	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	112	13	prone	prone	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	112	14	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	112	15	develop	develop	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	112	16	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	112	17	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	112	18	whole	whole	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	112	19	liver	liver	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	112	20	lesions	lesion	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	112	21	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	113	1	stimulation	stimulation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	113	2	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	113	3	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	113	4	may	may	MD
work_5r5e7ca2zncbpm64fpccqjkzhi	113	5	enhance	enhance	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	113	6	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	113	7	progression	progression	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	113	8	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	113	9	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	113	10	nodules	nodule	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	113	11	that	that	WDT
work_5r5e7ca2zncbpm64fpccqjkzhi	113	12	are	be	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	113	13	not	not	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	113	14	detected	detect	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	113	15	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	113	16	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	113	17	examination	examination	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	113	18	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	114	1	When	when	WRB
work_5r5e7ca2zncbpm64fpccqjkzhi	114	2	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	114	3	stage	stage	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	4	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	5	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	114	6	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	114	7	evaluated	evaluate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	8	using	use	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	114	9	more	more	RBR
work_5r5e7ca2zncbpm64fpccqjkzhi	114	10	sensitive	sensitive	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	114	11	methods	method	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	114	12	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	114	13	such	such	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	114	14	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	15	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	114	16	during	during	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	17	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	114	18	portography	portography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	19	and/or	and/or	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	114	20	superparamag-	superparamag-	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	21	netic	netic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	114	22	iron	iron	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	23	oxide	oxide	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	24	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	114	25	enhanced	enhance	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	26	gradient	gradient	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	27	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	114	28	recalled	recall	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	29	echo	echo	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	30	MRI	MRI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	114	31	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	114	32	24	24	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	114	33	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	114	34	29	29	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	114	35	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	114	36	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	114	37	extremely	extremely	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	114	38	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	114	39	focal	focal	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	114	40	nodules	nodule	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	114	41	can	can	MD
work_5r5e7ca2zncbpm64fpccqjkzhi	114	42	be	be	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	114	43	detected	detect	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	114	44	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	115	1	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	115	2	main	main	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	115	3	causes	cause	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	115	4	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	115	5	patient	patient	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	115	6	death	death	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	115	7	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	115	8	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	115	9	present	present	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	115	10	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	115	11	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	115	12	related	relate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	115	13	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	115	14	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	115	15	failure	failure	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	115	16	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	115	17	not	not	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	115	18	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	115	19	tumor	tumor	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	115	20	progression	progression	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	115	21	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	115	22	either	either	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	115	23	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	115	24	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	116	1	Although	although	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	2	it	-PRON-	PRP
work_5r5e7ca2zncbpm64fpccqjkzhi	116	3	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	116	4	reported	report	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	5	that	that	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	6	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	116	7	improves	improve	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	116	8	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	9	control	control	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	10	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	11	large	large	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	116	12	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	116	13	size	size	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	14	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	116	15	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	116	16	our	-PRON-	PRP$
work_5r5e7ca2zncbpm64fpccqjkzhi	116	17	data	datum	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	116	18	suggest	suggest	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	116	19	that	that	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	20	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	116	21	prog-	prog-	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	116	22	nosis	nosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	23	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	24	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	116	25	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	26	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	116	27	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	28	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	116	29	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	116	30	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	116	31	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	116	32	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	33	diameter	diameter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	34	depends	depend	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	116	35	on	on	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	36	residual	residual	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	116	37	liver	liver	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	38	function	function	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	39	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	116	40	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	116	41	not	not	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	116	42	on	on	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	43	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	44	progression	progression	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	116	45	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	117	1	No	no	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	117	2	statistical	statistical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	117	3	significance	significance	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	4	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	117	5	found	find	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	6	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	7	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	117	8	present	present	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	117	9	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	10	which	which	WDT
work_5r5e7ca2zncbpm64fpccqjkzhi	117	11	showed	show	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	117	12	that	that	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	13	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	117	14	mean	mean	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	117	15	patient	patient	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	117	16	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	17	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	18	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	117	19	shorter	short	JJR
work_5r5e7ca2zncbpm64fpccqjkzhi	117	20	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	21	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	117	22	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	117	23	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	117	24	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	117	25	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	26	than	than	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	27	that	that	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	117	28	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	29	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	117	30	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	117	31	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	117	32	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	117	33	group	group	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	117	34	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	118	1	Therefore	therefore	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	118	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	118	3	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	118	4	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	118	5	control	control	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	118	6	may	may	MD
work_5r5e7ca2zncbpm64fpccqjkzhi	118	7	not	not	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	118	8	directly	directly	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	118	9	contribute	contribute	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	118	10	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	118	11	patient	patient	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	118	12	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	118	13	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	118	14	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	119	1	A	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	119	2	number	number	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	119	3	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	119	4	limitations	limitation	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	119	5	should	should	MD
work_5r5e7ca2zncbpm64fpccqjkzhi	119	6	be	be	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	119	7	noted	note	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	119	8	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	120	1	Although	although	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	120	2	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	120	3	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	120	4	enrolled	enrol	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	120	5	at	at	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	120	6	different	different	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	120	7	sites	site	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	120	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	120	9	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	120	10	relatively	relatively	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	120	11	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	120	12	number	number	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	120	13	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	120	14	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	120	15	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	120	16	unable	unable	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	120	17	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	120	18	participate	participate	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	120	19	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	120	20	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	120	21	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	120	22	follow	follow	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	120	23	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	120	24	up	up	RP
work_5r5e7ca2zncbpm64fpccqjkzhi	120	25	period	period	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	120	26	was	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	120	27	short	short	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	120	28	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	121	1	All	all	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	121	2	but	but	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	121	3	two	two	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	121	4	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	121	5	were	be	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	121	6	virus	virus	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	121	7	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	121	8	related	relate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	121	9	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	121	10	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	122	1	Recently	recently	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	122	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	122	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	122	4	incidence	incidence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	122	5	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	122	6	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	122	7	from	from	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	122	8	non	non	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	122	9	-	-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	122	10	alcoholic	alcoholic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	122	11	steato-	steato-	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	122	12	hepatitis	hepatitis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	122	13	has	have	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	122	14	been	be	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	122	15	on	on	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	122	16	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	122	17	increase	increase	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	122	18	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	122	19	its	-PRON-	PRP$
work_5r5e7ca2zncbpm64fpccqjkzhi	122	20	characteristics	characteristic	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	122	21	are	be	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	122	22	reportedly	reportedly	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	122	23	different	different	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	122	24	from	from	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	122	25	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	122	26	resulting	result	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	122	27	from	from	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	122	28	HCV	HCV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	122	29	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	122	30	HBV	HBV	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	122	31	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	122	32	30	30	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	122	33	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	122	34	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	123	1	However	however	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	123	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	123	3	this	this	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	123	4	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	123	5	used	use	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	123	6	random	random	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	123	7	assignment	assignment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	123	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	123	9	providing	provide	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	123	10	us	-PRON-	PRP
work_5r5e7ca2zncbpm64fpccqjkzhi	123	11	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	123	12	important	important	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	123	13	information	information	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	123	14	regarding	regard	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	123	15	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	123	16	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	123	17	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	123	18	relatively	relatively	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	123	19	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	123	20	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	123	21	size	size	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	123	22	virus	virus	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	123	23	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	123	24	related	relate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	123	25	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	123	26	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	124	1	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	124	2	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	124	3	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	124	4	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	124	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	124	6	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	124	7	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	124	8	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	124	9	diameter	diameter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	124	10	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	124	11	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	124	12	additional	additional	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	124	13	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	124	14	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	124	15	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	124	16	did	do	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	124	17	not	not	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	124	18	markedly	markedly	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	124	19	improve	improve	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	124	20	patient	patient	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	124	21	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	124	22	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	125	1	Moreover	moreover	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	125	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	125	3	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	125	4	additional	additional	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	125	5	TACE	TACE	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	125	6	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	7	appeared	appear	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	125	8	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	125	9	shorten	shorten	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	125	10	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	125	11	patient	patient	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	125	12	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	13	time	time	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	14	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	15	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	125	16	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	17	did	do	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	125	18	not	not	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	125	19	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	125	20	at	at	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	21	least	least	JJS
work_5r5e7ca2zncbpm64fpccqjkzhi	125	22	notably	notably	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	125	23	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	125	24	damage	damage	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	25	residual	residual	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	125	26	liver	liver	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	27	function	function	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	28	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	125	29	stimulated	stimulate	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	125	30	new	new	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	125	31	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	32	growth	growth	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	33	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	34	lesions	lesion	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	125	35	other	other	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	125	36	than	than	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	37	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	125	38	primary	primary	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	125	39	one	one	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	125	40	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	126	1	Additionally	additionally	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	126	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	126	3	other	other	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	126	4	modalities	modality	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	126	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	126	6	such	such	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	126	7	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	126	8	radio	radio	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	126	9	frequency	frequency	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	126	10	ablation	ablation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	126	11	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	126	12	RfA	RfA	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	126	13	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	126	14	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	126	15	are	be	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	126	16	available	available	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	126	17	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	127	1	such	such	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	127	2	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	127	3	modalities	modality	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	127	4	are	be	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	127	5	considered	consider	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	127	6	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	127	7	be	be	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	127	8	superior	superior	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	127	9	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	127	10	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	127	11	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	127	12	local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	127	13	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	127	14	control	control	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	127	15	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	127	16	attack	attack	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	127	17	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	127	18	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	127	19	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	127	20	pin	pin	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	127	21	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	127	22	point	point	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	127	23	manner	manner	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	127	24	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	127	25	31	31	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	127	26	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	127	27	35	35	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	127	28	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	127	29	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	128	1	Thus	thus	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	128	2	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	128	3	our	-PRON-	PRP$
work_5r5e7ca2zncbpm64fpccqjkzhi	128	4	data	datum	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	128	5	suggest	suggest	VBP
work_5r5e7ca2zncbpm64fpccqjkzhi	128	6	that	that	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	128	7	RfA	RfA	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	128	8	alone	alone	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	128	9	as	as	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	128	10	well	well	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	128	11	as	as	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	128	12	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	128	13	may	may	MD
work_5r5e7ca2zncbpm64fpccqjkzhi	128	14	be	be	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	128	15	recommended	recommend	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	128	16	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	128	17	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	128	18	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	128	19	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	128	20	relatively	relatively	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	128	21	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	128	22	HCCs	hcc	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	128	23	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	128	24	2	2	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	128	25	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	128	26	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	128	27	cm	cm	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	128	28	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	128	29	diameter	diameter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	128	30	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	129	1	Acknowledgements	acknowledgement	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	129	2	We	-PRON-	PRP
work_5r5e7ca2zncbpm64fpccqjkzhi	129	3	would	would	MD
work_5r5e7ca2zncbpm64fpccqjkzhi	129	4	like	like	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	129	5	to	to	TO
work_5r5e7ca2zncbpm64fpccqjkzhi	129	6	thank	thank	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	129	7	dr	dr	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	129	8	Hidetsugu	Hidetsugu	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	129	9	saitou	saitou	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	129	10	who	who	WP
work_5r5e7ca2zncbpm64fpccqjkzhi	129	11	supervised	supervise	VBD
work_5r5e7ca2zncbpm64fpccqjkzhi	129	12	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	129	13	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	129	14	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	130	1	References	reference	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	130	2	1	1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	130	3	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	131	1	Okita	Okita	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	131	2	k	k	XX
work_5r5e7ca2zncbpm64fpccqjkzhi	131	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	131	4	Clinical	clinical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	131	5	aspects	aspect	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	131	6	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	131	7	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	131	8	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	131	9	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	131	10	Japan	Japan	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	131	11	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	132	1	Intern	Intern	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	132	2	Med	Med	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	132	3	45	45	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	132	4	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	132	5	229	229	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	132	6	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	132	7	233	233	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	132	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	132	9	2006	2006	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	132	10	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	133	1	2	2	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	133	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	134	1	Livraghi	Livraghi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	134	2	T	T	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	134	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	134	4	festi	festi	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	134	5	d	d	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	134	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	134	7	Monti	Monti	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	134	8	f	f	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	134	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	134	10	salmi	salmi	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	134	11	A	A	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	134	12	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	134	13	Vettori	Vettori	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	134	14	C	C	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	134	15	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	134	16	us	-PRON-	PRP
work_5r5e7ca2zncbpm64fpccqjkzhi	134	17	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	134	18	guided	guide	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	134	19	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	134	20	alcohol	alcohol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	134	21	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	134	22	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	134	23	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	134	24	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	134	25	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	134	26	abdominal	abdominal	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	134	27	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	134	28	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	135	1	Radiology	radiology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	135	2	161	161	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	135	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	135	4	309	309	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	135	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	135	6	312	312	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	135	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	135	8	1986	1986	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	135	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	136	1	3	3	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	136	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	137	1	Ohoto	Ohoto	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	137	2	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	137	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	137	4	Ebara	Ebara	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	137	5	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	137	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	137	7	Watanabe	Watanabe	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	137	8	y	y	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	137	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	137	10	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	137	11	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	137	12	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	137	13	Percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	137	14	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	137	15	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	137	16	(	(	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	137	17	PEI	PEI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	137	18	)	)	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	137	19	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	137	20	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	137	21	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	137	22	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	137	23	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	137	24	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	138	1	Evaluation	evaluation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	138	2	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	138	3	its	-PRON-	PRP$
work_5r5e7ca2zncbpm64fpccqjkzhi	138	4	utility	utility	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	138	5	on	on	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	138	6	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	138	7	basis	basis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	138	8	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	138	9	tumor	tumor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	138	10	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	138	11	images	image	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	138	12	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	138	13	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	138	14	after	after	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	138	15	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	138	16	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	139	1	Jpn	Jpn	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	139	2	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	139	3	Med	Med	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	139	4	Imaging	Imaging	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	139	5	7	7	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	139	6	:	:	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	139	7	25	25	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	139	8	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	139	9	33	33	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	139	10	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	139	11	1988	1988	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	139	12	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	140	1	4	4	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	140	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	141	1	Livraghi	Livraghi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	141	2	T	T	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	141	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	141	4	giorgio	giorgio	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	141	5	A	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	141	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	141	7	Marin	Marin	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	141	8	g	g	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	141	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	141	10	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	141	11	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	141	12	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	141	13	Hepatocellular	Hepatocellular	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	141	14	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	141	15	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	141	16	cirrhosis	cirrhosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	141	17	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	141	18	746	746	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	141	19	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	141	20	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	141	21	long	long	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	141	22	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	141	23	term	term	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	141	24	results	result	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	141	25	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	141	26	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	141	27	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	141	28	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	141	29	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	142	1	Radiology	radiology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	142	2	197	197	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	142	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	142	4	101	101	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	142	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	142	6	108	108	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	142	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	142	8	1995	1995	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	142	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	143	1	5	5	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	143	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	143	3	kotoh	kotoh	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	4	k	k	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	143	6	sakai	sakai	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	7	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	143	9	sakamoto	sakamoto	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	10	s	s	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	143	12	Nakayama	Nakayama	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	13	s	s	POS
work_5r5e7ca2zncbpm64fpccqjkzhi	143	14	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	143	15	satoh	satoh	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	16	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	17	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	143	18	Morotomi	Morotomi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	19	I	I	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	20	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	143	21	Nawata	Nawata	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	22	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	143	23	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	143	24	The	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	143	25	effect	effect	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	143	26	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	143	27	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	143	28	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	143	29	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	143	30	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	143	31	on	on	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	143	32	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	143	33	solitary	solitary	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	143	34	hepatocellular	hepatocellular	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	143	35	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	143	36	is	be	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	143	37	comparable	comparable	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	143	38	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	143	39	that	that	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	143	40	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	143	41	hepatectomy	hepatectomy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	143	42	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	144	1	Am	Am	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	144	2	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	144	3	gastroenterol	gastroenterol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	144	4	89	89	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	144	5	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	144	6	194	194	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	144	7	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	144	8	198	198	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	144	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	144	10	1994	1994	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	144	11	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	145	1	6	6	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	145	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	146	1	Castells	Castells	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	146	2	A	A	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	146	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	146	4	Bruix	Bruix	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	146	5	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	146	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	146	7	Bru	Bru	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	146	8	C	C	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	146	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	146	10	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	146	11	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	146	12	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	146	13	Treatment	Treatment	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	146	14	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	146	15	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	146	16	hepatocel-	hepatocel-	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	146	17	lular	lular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	146	18	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	146	19	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	146	20	cirrhotic	cirrhotic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	146	21	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	146	22	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	146	23	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	146	24	cohort	cohort	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	146	25	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	146	26	comparing	compare	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	146	27	surgical	surgical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	146	28	resection	resection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	146	29	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	146	30	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	146	31	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	146	32	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	146	33	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	147	1	Hepatology	hepatology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	147	2	18	18	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	147	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	147	4	1121	1121	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	147	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	147	6	1126	1126	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	147	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	147	8	1993	1993	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	147	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	148	1	7	7	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	148	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	148	3	koda	koda	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	148	4	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	148	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	148	6	Murawaki	Murawaki	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	148	7	y	y	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	148	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	148	9	Mitsuda	Mitsuda	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	148	10	A	A	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	148	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	148	12	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	148	13	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	148	14	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	148	15	Predictive	predictive	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	148	16	factors	factor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	148	17	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	148	18	intrahepatic	intrahepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	148	19	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	148	20	after	after	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	148	21	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	148	22	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	148	23	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	148	24	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	148	25	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	148	26	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	148	27	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	148	28	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	148	29	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	149	1	Cancer	cancer	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	149	2	88	88	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	149	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	149	4	529	529	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	149	5	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	149	6	537	537	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	149	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	149	8	2000	2000	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	149	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	150	1	8	8	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	150	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	151	1	Ishii	Ishii	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	151	2	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	151	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	151	4	Okada	Okada	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	151	5	s	s	POS
work_5r5e7ca2zncbpm64fpccqjkzhi	151	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	151	7	Nose	Nose	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	151	8	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	151	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	151	10	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	151	11	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	151	12	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	151	13	Local	local	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	151	14	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	151	15	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	151	16	hepatocel-	hepatocel-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	151	17	lular	lular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	151	18	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	151	19	after	after	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	151	20	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	151	21	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	151	22	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	151	23	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	152	1	Cancer	cancer	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	152	2	77	77	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	152	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	152	4	1792	1792	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	152	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	152	6	1796	1796	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	152	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	152	8	1996	1996	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	152	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	153	1	9	9	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	153	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	154	1	Castellano	Castellano	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	154	2	L	L	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	154	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	154	4	Calandra	Calandra	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	154	5	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	154	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	154	7	del	del	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	154	8	Vecchio	Vecchio	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	154	9	Blanco	Blanco	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	154	10	C	C	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	154	11	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	154	12	de	de	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	154	13	sio	sio	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	154	14	I	-PRON-	PRP
work_5r5e7ca2zncbpm64fpccqjkzhi	154	15	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	154	16	Predictive	predictive	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	154	17	factors	factor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	154	18	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	19	survival	survival	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	20	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	154	21	intrahepatic	intrahepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	154	22	recurrence	recurrence	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	23	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	24	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	154	25	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	26	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	27	cirrhosis	cirrhosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	28	after	after	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	29	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	154	30	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	31	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	32	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	154	33	analysis	analysis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	34	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	154	35	71	71	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	154	36	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	154	37	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	155	1	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	155	2	Hepatol	Hepatol	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	155	3	27	27	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	155	4	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	155	5	862	862	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	155	6	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	155	7	870	870	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	155	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	155	9	1997	1997	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	155	10	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	156	1	10	10	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	156	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	157	1	Ohnishi	Ohnishi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	157	2	k	k	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	157	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	157	4	yoshioka	yoshioka	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	157	5	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	157	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	157	7	Ito	Ito	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	157	8	s	s	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	157	9	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	157	10	fujiwara	fujiwara	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	157	11	k	k	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	157	12	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	157	13	Prospective	Prospective	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	157	14	randomized	randomize	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	157	15	controlled	controlled	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	157	16	trial	trial	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	157	17	comparing	compare	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	157	18	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	157	19	acetic	acetic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	157	20	acid	acid	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	157	21	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	157	22	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	157	23	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	157	24	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	157	25	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	157	26	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	157	27	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	157	28	hepatocel-	hepatocel-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	157	29	lular	lular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	157	30	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	157	31	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	158	1	Hepatology	hepatology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	158	2	27	27	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	158	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	158	4	67	67	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	158	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	158	6	72	72	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	158	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	158	8	1998	1998	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	158	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	159	1	11	11	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	159	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	159	3	doyon	doyon	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	159	4	d	d	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	159	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	159	6	Mouzon	Mouzon	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	159	7	A	A	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	159	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	159	9	Jourde	Jourde	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	159	10	AM	AM	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	159	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	159	12	Regensberg	Regensberg	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	159	13	C	C	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	159	14	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	159	15	frileux	frileux	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	159	16	C	C	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	159	17	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	159	18	[	[	-LRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	159	19	Hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	159	20	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	159	21	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	159	22	embolization	embolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	159	23	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	159	24	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	159	25	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	159	26	malignant	malignant	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	159	27	liver	liver	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	159	28	tumours	tumour	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	159	29	]	]	-RRB-
work_5r5e7ca2zncbpm64fpccqjkzhi	159	30	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	160	1	Ann	Ann	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	160	2	Radiol	Radiol	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	160	3	17	17	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	160	4	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	160	5	593	593	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	160	6	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	160	7	603	603	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	160	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	160	9	1974	1974	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	160	10	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	161	1	12	12	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	161	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	161	3	yamada	yamada	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	161	4	R	R	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	161	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	161	6	sato	sato	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	161	7	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	161	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	161	9	kawabata	kawabata	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	161	10	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	161	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	161	12	Nakatsuka	Nakatsuka	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	161	13	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	161	14	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	161	15	Nakamura	Nakamura	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	161	16	k	k	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	161	17	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	161	18	Takashima	Takashima	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	161	19	s	s	POS
work_5r5e7ca2zncbpm64fpccqjkzhi	161	20	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	161	21	Hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	161	22	artery	artery	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	161	23	embolization	embolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	161	24	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	161	25	120	120	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	161	26	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	161	27	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	161	28	unresectable	unresectable	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	161	29	hepatoma	hepatoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	161	30	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	162	1	Radiology	radiology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	162	2	148	148	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	162	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	162	4	397	397	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	162	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	162	6	401	401	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	162	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	162	8	1983	1983	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	162	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	163	1	13	13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	163	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	164	1	Choi	Choi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	164	2	BI	BI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	164	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	164	4	kim	kim	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	164	5	HC	HC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	164	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	164	7	Han	Han	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	164	8	Jk	Jk	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	164	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	164	10	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	164	11	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	164	12	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	164	13	Therapeutic	therapeutic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	164	14	effect	effect	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	164	15	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	164	16	tran-	tran-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	164	17	scatheter	scatheter	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	164	18	oily	oily	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	164	19	chemoembolization	chemoembolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	164	20	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	164	21	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	164	22	encapsulated	encapsulated	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	164	23	nodular	nodular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	164	24	hepatocellular	hepatocellular	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	164	25	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	164	26	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	164	27	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	164	28	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	164	29	pathologic	pathologic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	164	30	findings	finding	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	164	31	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	165	1	Radiology	radiology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	165	2	182	182	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	165	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	165	4	709	709	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	165	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	165	6	713	713	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	165	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	165	8	1992	1992	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	165	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	166	1	14	14	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	166	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	167	1	Bruix	Bruix	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	167	2	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	167	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	167	4	Llovet	Llovet	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	167	5	JM	JM	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	167	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	167	7	Castells	Castells	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	167	8	A	A	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	167	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	167	10	et	et	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	11	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	167	12	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	167	13	Transarterial	transarterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	167	14	embolization	embolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	15	versus	versus	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	16	symptomatic	symptomatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	167	17	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	18	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	19	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	167	20	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	21	advanced	advanced	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	167	22	hepato-	hepato-	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	167	23	cellular	cellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	167	24	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	25	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	167	26	results	result	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	167	27	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	28	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	167	29	randomized	randomized	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	167	30	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	167	31	controlled	control	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	32	trial	trial	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	33	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	34	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	167	35	single	single	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	167	36	institution	institution	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	167	37	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	168	1	Hepatology	hepatology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	168	2	27	27	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	168	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	168	4	1578	1578	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	168	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	168	6	1583	1583	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	168	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	168	8	1998	1998	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	168	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	169	1	ONCOLOGY	ONCOLOGY	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	169	2	LETTERS	letter	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	169	3	1	1	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	169	4	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	169	5	855	855	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	169	6	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	169	7	859	859	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	169	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	169	9	2010	2010	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	169	10	859	859	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	169	11	15	15	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	169	12	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	169	13	kobayashi	kobayashi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	169	14	s	s	POS
work_5r5e7ca2zncbpm64fpccqjkzhi	169	15	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	169	16	Nakanuma	Nakanuma	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	169	17	y	y	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	169	18	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	169	19	Terada	Terada	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	169	20	T	T	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	169	21	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	169	22	Matsui	Matsui	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	169	23	O	o	XX
work_5r5e7ca2zncbpm64fpccqjkzhi	169	24	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	169	25	Postmortem	Postmortem	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	169	26	survey	survey	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	27	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	28	bile	bile	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	29	duct	duct	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	30	necrosis	necrosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	31	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	169	32	biloma	biloma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	33	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	34	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	169	35	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	36	after	after	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	37	transcatheter	transcatheter	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	169	38	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	169	39	chemoembolization	chemoembolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	40	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	41	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	169	42	relevance	relevance	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	43	to	to	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	44	microvascular	microvascular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	169	45	damage	damage	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	46	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	47	peribiliary	peribiliary	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	169	48	capillary	capillary	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	169	49	plexus	plexus	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	169	50	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	170	1	Am	Am	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	170	2	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	170	3	gastroenterol	gastroenterol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	170	4	88	88	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	170	5	:	:	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	170	6	1410	1410	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	170	7	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	170	8	1415	1415	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	170	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	170	10	1993	1993	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	170	11	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	171	1	16	16	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	171	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	172	1	Chung	Chung	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	2	JW	JW	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	172	4	Park	Park	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	5	JH	JH	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	172	7	Han	Han	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	8	Jk	Jk	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	172	10	Choi	Choi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	11	BI	BI	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	12	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	172	13	Han	Han	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	14	MC	MC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	15	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	172	16	Lee	Lee	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	17	Hs	Hs	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	18	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	172	19	kim	kim	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	20	Cy	Cy	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	172	21	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	172	22	Hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	172	23	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	172	24	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	172	25	predisposing	predispose	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	172	26	factors	factor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	172	27	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	172	28	complications	complication	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	172	29	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	172	30	transcatheter	transcathet	JJR
work_5r5e7ca2zncbpm64fpccqjkzhi	172	31	oily	oily	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	172	32	chemoembolization	chemoembolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	172	33	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	173	1	Radiology	radiology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	173	2	198	198	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	173	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	173	4	33	33	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	173	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	173	6	40	40	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	173	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	173	8	1996	1996	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	173	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	174	1	17	17	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	174	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	174	3	sakamoto	sakamoto	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	174	4	I	I	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	174	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	174	6	Aso	Aso	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	174	7	N	N	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	174	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	174	9	Nagaoka	Nagaoka	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	174	10	k	k	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	174	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	174	12	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	174	13	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	174	14	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	174	15	Complications	complication	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	174	16	associated	associate	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	174	17	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	174	18	transcatheter	transcathet	JJR
work_5r5e7ca2zncbpm64fpccqjkzhi	174	19	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	174	20	embolization	embolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	174	21	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	174	22	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	174	23	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	174	24	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	175	1	Radiographics	radiographic	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	175	2	18	18	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	175	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	175	4	605	605	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	175	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	175	6	619	619	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	175	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	175	8	1998	1998	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	175	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	176	1	18	18	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	176	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	177	1	Tanaka	Tanaka	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	177	2	k	k	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	177	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	177	4	Okazaki	Okazaki	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	177	5	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	177	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	177	7	Nakamura	Nakamura	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	177	8	s	s	POS
work_5r5e7ca2zncbpm64fpccqjkzhi	177	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	177	10	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	177	11	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	177	12	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	177	13	Hepatocellular	Hepatocellular	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	177	14	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	177	15	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	177	16	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	177	17	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	177	18	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	177	19	combination	combination	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	177	20	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	177	21	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	177	22	transcath-	transcath-	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	177	23	eter	eter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	177	24	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	177	25	embolization	embolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	177	26	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	177	27	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	177	28	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	177	29	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	177	30	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	178	1	Radiology	radiology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	178	2	179	179	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	178	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	178	4	713	713	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	178	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	178	6	717	717	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	178	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	178	8	1991	1991	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	178	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	179	1	19	19	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	179	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	179	3	koda	koda	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	179	4	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	179	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	179	6	Murawaki	Murawaki	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	179	7	y	y	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	179	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	179	9	Mitsuda	Mitsuda	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	179	10	A	A	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	179	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	179	12	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	179	13	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	179	14	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	179	15	Combination	combination	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	16	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	17	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	18	transcatheter	transcathet	JJR
work_5r5e7ca2zncbpm64fpccqjkzhi	179	19	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	179	20	chemoembolization	chemoembolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	21	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	179	22	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	179	23	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	24	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	25	compared	compare	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	26	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	27	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	179	28	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	29	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	30	alone	alone	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	179	31	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	32	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	179	33	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	34	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	179	35	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	179	36	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	37	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	179	38	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	179	39	randomized	randomized	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	179	40	control	control	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	41	study	study	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	179	42	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	180	1	Cancer	cancer	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	180	2	92	92	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	180	3	:	:	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	180	4	1516	1516	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	180	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	180	6	1524	1524	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	180	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	180	8	2001	2001	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	180	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	181	1	20	20	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	181	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	182	1	Li	Li	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	2	X	X	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	182	4	feng	feng	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	5	gs	gs	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	182	7	zheng	zheng	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	8	Cs	Cs	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	182	10	zhuo	zhuo	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	11	Ck	Ck	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	12	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	182	13	Liu	Liu	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	14	X	X	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	15	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	182	16	Expression	expression	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	17	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	18	plasma	plasma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	19	vascular	vascular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	182	20	endotherial	endotherial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	182	21	growth	growth	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	22	factor	factor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	23	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	24	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	182	25	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	26	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	182	27	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	28	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	182	29	effect	effect	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	30	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	31	transcatheter	transcatheter	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	32	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	182	33	chemoembolization	chemoembolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	34	therapy	therapy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	35	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	36	plasma	plasma	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	182	37	vascular	vascular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	182	38	endothelial	endothelial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	182	39	growth	growth	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	40	factor	factor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	41	level	level	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	182	42	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	183	1	World	World	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	183	2	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	183	3	gastroenterol	gastroenterol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	183	4	10	10	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	183	5	:	:	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	183	6	2878	2878	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	183	7	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	183	8	2882	2882	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	183	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	183	10	2004	2004	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	183	11	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	184	1	21	21	LS
work_5r5e7ca2zncbpm64fpccqjkzhi	184	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	184	3	suzuki	suzuki	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	4	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	184	6	Mori	Mori	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	7	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	184	9	kawaguchi	kawaguchi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	10	C	C	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	184	12	Adachi	Adachi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	13	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	14	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	184	15	Miura	Miura	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	16	s	s	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	17	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	184	18	Ishii	Ishii	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	19	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	184	20	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	184	21	serum	serum	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	184	22	vascular	vascular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	184	23	endothelial	endothelial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	184	24	growth	growth	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	184	25	factor	factor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	184	26	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	184	27	the	the	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	184	28	course	course	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	184	29	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	184	30	transcatheter	transcatheter	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	184	31	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	184	32	embolization	embolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	184	33	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	184	34	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	184	35	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	184	36	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	185	1	Int	Int	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	185	2	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	185	3	Oncol	Oncol	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	185	4	14	14	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	185	5	:	:	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	185	6	1087	1087	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	185	7	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	185	8	1090	1090	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	185	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	185	10	1999	1999	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	185	11	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	186	1	22	22	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	186	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	186	3	kobayashi	kobayashi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	4	N	N	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	186	6	Ishii	Ishii	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	7	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	186	9	ueno	ueno	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	10	y	y	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	186	12	kisara	kisara	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	13	N	N	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	14	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	186	15	Chida	Chida	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	16	N	N	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	17	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	186	18	Iwasaki	Iwasaki	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	19	T	T	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	20	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	186	21	Toyota	Toyota	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	22	T	T	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	23	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	186	24	Coexpression	coexpression	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	186	25	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	186	26	Bcl-2	Bcl-2	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	186	27	protein	protein	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	186	28	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	186	29	vascular	vascular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	186	30	endothelial	endothelial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	186	31	growth	growth	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	186	32	factor	factor	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	186	33	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	186	34	hepatocellular	hepatocellular	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	186	35	carcinomas	carcinoma	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	186	36	treated	treat	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	186	37	by	by	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	186	38	chemoem-	chemoem-	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	186	39	bolization	bolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	186	40	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	187	1	Liver	Liver	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	187	2	19	19	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	187	3	:	:	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	187	4	25	25	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	187	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	187	6	31	31	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	187	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	187	8	1999	1999	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	187	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	188	1	23	23	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	188	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	188	3	gupta	gupta	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	188	4	s	s	POS
work_5r5e7ca2zncbpm64fpccqjkzhi	188	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	188	6	kobayashi	kobayashi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	188	7	s	s	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	188	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	188	9	Phongkitkarun	Phongkitkarun	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	188	10	s	s	POS
work_5r5e7ca2zncbpm64fpccqjkzhi	188	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	188	12	Broemeling	Broemeling	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	188	13	Ld	Ld	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	188	14	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	188	15	kan	kan	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	188	16	z	z	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	188	17	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	188	18	Effect	effect	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	188	19	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	188	20	transcatheter	transcatheter	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	188	21	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	188	22	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	188	23	embolization	embolization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	188	24	on	on	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	188	25	angiogenesis	angiogenesis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	188	26	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	188	27	an	an	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	188	28	animal	animal	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	188	29	model	model	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	188	30	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	189	1	Invest	invest	VB
work_5r5e7ca2zncbpm64fpccqjkzhi	189	2	Radiol	Radiol	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	189	3	4	4	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	189	4	:	:	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	189	5	516	516	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	189	6	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	189	7	521	521	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	189	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	189	9	2006	2006	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	189	10	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	190	1	24	24	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	190	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	190	3	kim	kim	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	190	4	HC	HC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	190	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	190	6	kim	kim	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	190	7	Tk	Tk	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	190	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	190	9	sung	sung	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	190	10	kB	kB	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	190	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	190	12	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	190	13	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	190	14	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	190	15	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	190	16	during	during	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	190	17	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	190	18	arteriog-	arteriog-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	190	19	raphy	raphy	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	190	20	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	190	21	portography	portography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	190	22	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	190	23	an	an	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	190	24	illustrative	illustrative	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	190	25	review	review	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	190	26	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	191	1	Radiographics	Radiographics	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	191	2	22	22	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	191	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	191	4	1041	1041	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	191	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	191	6	1051	1051	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	191	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	191	8	2002	2002	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	191	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	192	1	25	25	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	192	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	193	1	Heiken	Heiken	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	2	JP	JP	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	193	4	Weyman	Weyman	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	5	PJ	PJ	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	193	7	Lee	Lee	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	8	Jk	Jk	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	193	10	Balfe	Balfe	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	11	dM	dM	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	12	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	193	13	Picus	Picus	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	14	d	d	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	15	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	193	16	Brunt	Brunt	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	17	EM	EM	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	18	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	193	19	flye	flye	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	193	20	MW	mw	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	193	21	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	193	22	detection	detection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	193	23	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	193	24	focal	focal	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	193	25	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	193	26	masses	masse	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	193	27	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	193	28	prospective	prospective	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	193	29	evaluation	evaluation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	193	30	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	193	31	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	32	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	193	33	delayed	delay	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	193	34	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	35	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	193	36	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	37	during	during	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	193	38	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	193	39	portography	portography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	193	40	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	193	41	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	193	42	MR	MR	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	193	43	imaging	imaging	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	193	44	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	194	1	Radiology	radiology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	194	2	171	171	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	194	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	194	4	47	47	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	194	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	194	6	51	51	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	194	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	194	8	1989	1989	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	194	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	195	1	26	26	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	195	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	195	3	yu	yu	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	4	Js	Js	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	195	6	kim	kim	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	7	kW	kW	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	195	9	Lee	Lee	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	10	JT	JT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	11	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	195	12	yoo	yoo	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	13	Hs	Hs	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	14	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	195	15	MR	MR	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	16	imaging	image	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	195	17	during	during	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	195	18	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	195	19	portography	portography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	195	20	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	195	21	assessment	assessment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	195	22	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	195	23	hepatocellular	hepatocellular	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	24	carcinoma	carcinoma	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	25	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	195	26	comparison	comparison	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	195	27	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	195	28	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	195	29	during	during	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	195	30	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	195	31	portography	portography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	195	32	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	196	1	Am	Am	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	196	2	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	196	3	Roentgenol	Roentgenol	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	196	4	170	170	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	196	5	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	196	6	1501	1501	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	196	7	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	196	8	1506	1506	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	196	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	196	10	1998	1998	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	196	11	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	197	1	27	27	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	197	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	197	3	kanematsu	kanematsu	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	197	4	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	197	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	197	6	Hoshi	Hoshi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	197	7	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	197	8	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	197	9	Murakami	Murakami	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	197	10	T	T	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	197	11	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	197	12	detection	detection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	197	13	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	197	14	hepato-	hepato-	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	197	15	cellular	cellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	197	16	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	197	17	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	197	18	patients	patient	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	197	19	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	197	20	cirrhosis	cirrhosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	197	21	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	197	22	MR	MR	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	197	23	imaging	image	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	197	24	versus	versus	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	197	25	angiographically	angiographically	RB
work_5r5e7ca2zncbpm64fpccqjkzhi	197	26	assisted	assist	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	197	27	helical	helical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	197	28	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	197	29	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	197	30	Am	Am	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	197	31	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	197	32	Roentgenol	Roentgenol	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	197	33	169	169	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	197	34	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	197	35	1507	1507	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	197	36	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	197	37	1515	1515	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	197	38	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	197	39	1997	1997	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	197	40	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	198	1	28	28	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	198	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	199	1	Murakami	Murakami	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	199	2	T	T	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	199	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	199	4	Oi	Oi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	199	5	H	h	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	199	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	199	7	Hori	Hori	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	199	8	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	199	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	199	10	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	199	11	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	199	12	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	199	13	Helical	Helical	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	199	14	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	199	15	during	during	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	199	16	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	199	17	portography	portography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	199	18	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	199	19	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	199	20	arteriography	arteriography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	199	21	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	199	22	detecting	detect	VBG
work_5r5e7ca2zncbpm64fpccqjkzhi	199	23	hypervas-	hypervas-	PRP$
work_5r5e7ca2zncbpm64fpccqjkzhi	199	24	cular	cular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	199	25	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	199	26	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	199	27	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	200	1	Am	Am	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	200	2	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	200	3	Roentgenol	Roentgenol	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	200	4	169	169	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	200	5	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	200	6	131	131	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	200	7	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	200	8	135	135	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	200	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	200	10	1997	1997	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	200	11	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	201	1	29	29	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	201	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	201	3	kanematsu	kanematsu	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	4	M	M	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	201	6	Hoshi	Hoshi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	7	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	201	9	Imaeda	Imaeda	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	10	T	T	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	201	12	Murakami	Murakami	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	13	T	T	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	14	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	201	15	Inaba	Inaba	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	16	y	y	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	17	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	201	18	yokoyama	yokoyama	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	19	R	R	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	20	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	201	21	Nakamura	Nakamura	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	22	H	H	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	23	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	201	24	detection	detection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	201	25	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	201	26	characterization	characterization	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	201	27	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	201	28	hepatic	hepatic	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	201	29	tumors	tumor	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	201	30	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	201	31	value	value	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	201	32	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	201	33	combined	combine	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	201	34	helical	helical	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	201	35	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	36	hepatic	hepatic	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	201	37	arte-	arte-	NNS
work_5r5e7ca2zncbpm64fpccqjkzhi	201	38	riography	riography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	201	39	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	201	40	CT	CT	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	201	41	during	during	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	201	42	arterial	arterial	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	201	43	portography	portography	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	201	44	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	202	1	Am	Am	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	202	2	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	202	3	Roentgenol	Roentgenol	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	202	4	168	168	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	202	5	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	202	6	1193	1193	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	202	7	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	202	8	1198	1198	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	202	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	202	10	1997	1997	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	202	11	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	203	1	30	30	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	203	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	204	1	Page	page	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	204	2	JM	JM	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	204	3	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	204	4	Harrison	Harrison	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	204	5	sA	sA	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	204	6	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	204	7	NAsH	nash	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	204	8	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	204	9	HCC	HCC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	204	10	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	205	1	Clin	Clin	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	205	2	Liver	Liver	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	205	3	dis	dis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	205	4	13	13	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	205	5	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	205	6	631	631	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	205	7	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	205	8	647	647	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	205	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	205	10	2009	2009	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	205	11	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	206	1	31	31	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	206	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	206	3	shiina	shiina	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	206	4	s	s	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	206	5	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	206	6	Teratani	Teratani	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	206	7	T	T	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	206	8	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	206	9	Obi	Obi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	206	10	s	s	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	206	11	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	206	12	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	206	13	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	206	14	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	206	15	A	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	206	16	randomized	randomized	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	206	17	controlled	controlled	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	206	18	trial	trial	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	206	19	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	206	20	radiofrequency	radiofrequency	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	206	21	ablation	ablation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	206	22	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	206	23	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	206	24	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	206	25	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	206	26	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	206	27	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	206	28	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	206	29	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	207	1	gastroenterology	gastroenterology	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	207	2	129	129	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	207	3	:	:	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	207	4	122	122	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	207	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	207	6	130	130	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	207	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	207	8	2005	2005	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	207	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	208	1	32	32	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	208	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	209	1	Lin	Lin	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	2	sM	sM	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	209	4	Lin	Lin	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	5	CJ	CJ	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	209	7	Lin	Lin	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	8	CC	CC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	209	10	Hsu	Hsu	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	11	CW	CW	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	12	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	209	13	Chen	Chen	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	14	yC	yC	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	15	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	209	16	Radiofrequency	radiofrequency	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	209	17	ablation	ablation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	209	18	improves	improve	VBZ
work_5r5e7ca2zncbpm64fpccqjkzhi	209	19	prognosis	prognosis	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	209	20	compared	compare	VBN
work_5r5e7ca2zncbpm64fpccqjkzhi	209	21	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	209	22	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	209	23	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	209	24	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	209	25	hepatocellular	hepatocellular	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	26	carcinoma	carcinoma	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	27	≤4	≤4	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	28	cm	cm	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	209	29	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	210	1	gastroenterology	gastroenterology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	210	2	127	127	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	210	3	:	:	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	210	4	1714	1714	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	210	5	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	210	6	1723	1723	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	210	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	210	8	2004	2004	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	210	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	211	1	33	33	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	211	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	212	1	Lencioni	Lencioni	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	212	2	RA	RA	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	212	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	212	4	Allgaier	Allgaier	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	212	5	HP	HP	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	212	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	212	7	Cioni	Cioni	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	212	8	d	d	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	212	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	212	10	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	212	11	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	212	12	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	212	13	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	212	14	hepatocellular	hepatocellular	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	212	15	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	212	16	in	in	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	212	17	cirrhosis	cirrhosis	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	212	18	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	212	19	randomized	randomized	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	212	20	comparison	comparison	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	212	21	of	of	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	212	22	radio	radio	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	212	23	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	212	24	fre-	fre-	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	212	25	quency	quency	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	212	26	thermal	thermal	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	212	27	ablation	ablation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	212	28	versus	versus	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	212	29	percutaneous	percutaneous	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	212	30	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	212	31	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	212	32	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	213	1	Radiology	radiology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	213	2	228	228	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	213	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	213	4	235	235	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	213	5	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	213	6	240	240	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	213	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	213	8	2003	2003	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	213	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	214	1	34	34	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	214	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	215	1	Livraghi	Livraghi	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	2	T	T	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	215	4	goldberg	goldberg	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	5	sN	sN	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	215	7	Lazzaroni	Lazzaroni	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	8	s	s	POS
work_5r5e7ca2zncbpm64fpccqjkzhi	215	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	215	10	Meloni	Meloni	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	11	f	f	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	12	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	215	13	solbiati	solbiati	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	14	L	L	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	15	and	and	CC
work_5r5e7ca2zncbpm64fpccqjkzhi	215	16	gazelle	gazelle	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	17	gs	gs	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	18	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	215	19	small	small	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	215	20	hepatocellular	hepatocellular	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	215	21	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	215	22	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	215	23	treatment	treatment	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	215	24	with	with	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	215	25	radio	radio	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	215	26	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	215	27	frequency	frequency	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	215	28	ablation	ablation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	215	29	versus	versus	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	215	30	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	215	31	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	215	32	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	216	1	Radiology	radiology	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	216	2	210	210	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	216	3	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	216	4	655	655	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	216	5	-	-	HYPH
work_5r5e7ca2zncbpm64fpccqjkzhi	216	6	661	661	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	216	7	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	216	8	1999	1999	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	216	9	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	217	1	35	35	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	217	2	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	218	1	Brunello	Brunello	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	218	2	f	f	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	218	3	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	218	4	Veltri	Veltri	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	218	5	A	A	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	218	6	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	218	7	Carucci	Carucci	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	218	8	P	P	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	218	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	218	10	et	et	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	218	11	al	al	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	218	12	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	218	13	Radiofrequency	radiofrequency	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	218	14	ablation	ablation	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	218	15	versus	versus	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	218	16	ethanol	ethanol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	218	17	injection	injection	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	218	18	for	for	IN
work_5r5e7ca2zncbpm64fpccqjkzhi	218	19	early	early	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	218	20	hepatocellular	hepatocellular	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	218	21	carcinoma	carcinoma	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	218	22	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	218	23	a	a	DT
work_5r5e7ca2zncbpm64fpccqjkzhi	218	24	randomized	randomized	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	218	25	controlled	controlled	JJ
work_5r5e7ca2zncbpm64fpccqjkzhi	218	26	trial	trial	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	218	27	.	.	.
work_5r5e7ca2zncbpm64fpccqjkzhi	219	1	scand	scand	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	219	2	J	J	NNP
work_5r5e7ca2zncbpm64fpccqjkzhi	219	3	gastroenterol	gastroenterol	NN
work_5r5e7ca2zncbpm64fpccqjkzhi	219	4	43	43	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	219	5	:	:	:
work_5r5e7ca2zncbpm64fpccqjkzhi	219	6	727	727	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	219	7	-	-	SYM
work_5r5e7ca2zncbpm64fpccqjkzhi	219	8	735	735	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	219	9	,	,	,
work_5r5e7ca2zncbpm64fpccqjkzhi	219	10	2008	2008	CD
work_5r5e7ca2zncbpm64fpccqjkzhi	219	11	.	.	.